Subject index to volume 103

SUBJECT INDEX TO VOLUME 103

Abcesses, pancreatic and hepatic, in chronic pancreatitis, 103:560 Abdominal pain, in food allergy, 103:1075-srr Acalculous right upper quadrant pain, cholescintigraphy for, 103:1985-ss Acetaldehyde adduct, in alcoholic hepatitis, IgA antibody to, 103:1860 [rat), 1969 Acetic acid, colitis induced by (rat), 103:177 Acetylcholine in ileal cholinergic longitudinal muscle motor neurons (guinea pig), 103:961 lower esophageal sphincter response to, 103:1199 Acetylsalicylic acid in gastrointestinal bleeding, 103:862 ion permeation pathways in antrum affected by (Necturus), 103:1475 Achalasia manometry in, 103:1993-c pneumatic dilation in, 103:1732 upper esophageal sphincter belch reflex in, 103:1574, 103:1685-e vasoactive intestinal polypeptide effect on lower esophageal sphincter in, 103:377 Achlorhydria, endocrine cells during, gastrin receptor blockade effect on (rat), 103:1596 Acid back-diffusion injury, uremia in (rat), 103:1762 Acid infusion, esophageal, salivary secretion modulated by, 103:1833 Acid reflux, in esophagitis, 103:855 Acinar cells in acute necrotizing pancreatitis (opossum), 103:205 necrosis of, trypsinogen-activation peptides in (rat), lO3:1009 Acyl CoA:cholesterol acyl transferase, hepatic cholesterol metabolism in estrogen-treated men and, 103:1657 Adaptive bowel growth, mediators of, 103:462 Adaptive cytoprotection, as effect of chronic superficial injury to gastric mucosa (rat), 103:1179 Adenocarcinoma elongation factor 1 y-related sequence in, 103:98 lovastatin in inhibition of, 103:982 p53 gene mutation in, 103:892 Adenoma calcium-induced decrease of epithelial cell proliferation in, 103:92 mucosal hydrolases in, 103:1452 tenascin in, 103:400

Adenomatous polyps, rectal, ornithine decarboxylase and, 103:1562 Adenylate cyclase, in pancreatic tumor cell growth (rat), l03:1002 Adrenergic blockade in abolishment of gastric migrating motor complex (dog), 103:l49l . in mucin release (rabbit), 103:496 Adrenergic tone, in pancreatic secretion, 103:990 @-Adrenoreceptor agonist, internal anal sphincter resting pressure decreased by (opossum), l03:43 Aging Barrett’s esophagus and, lO3:1241 effect of on hepatic intracinar enzyme profile 103:351-c effect of on oropharyngeal swallowing, 103:823 Air, reflux of into biliary ducts, 103:l709c, 103:1989 Alanine, in T-cell activation, 103:255 Alanylglutamine, absorption in human intestine, 103:3 Albumin in calcium carbonate precipitation, 103:1277 in experimental pancreatitis (rat), 103:1916 in HBsAg-positive cirrhosis of the liver, 103:1630 in pancreatic transplantation, 103248 in sarcoidosis, 103:355-c Alcohol dehydrogenase activity, gastric, sex differences in (rat), 103:1804 Alcoholism IgA antibody to acetaldehyde adduct in, 103:1860 (rat), 1969-e IgA and interleukin 6 form positive secretory feedback loop in, 103:1296 nutritional therapy for, 103:357-c visual event-related P300 potentials in, 103:302 Alkaline phosphatase in neoplastic and hyperplastic large bowel lesions, 103:1452 thyroid hormone in differential regulation of (rat), 103:1529 Alkaline reflux, in esophagitis, 103:855 Allergies, food, basic mechanisms of pathophysiology, 103:107%srr Allogeneic immune response, in cholestasis, 103:617 Allopurinol, in reduction of early midzonal oxidative stress, 103:994 American Gastroenterological Association Governing Board, training and education policy statement by, 103:1127

KEY TO ABBREVIATIONS

cch-clinical challenges cr-case report e-editorial ss-selected summary srr-special reports and reviews

br-book review brep-brief report c-correspondence cc-clinical conference

Amino acids in cirrhosis, 103:601 in hepatocyte pig receptor expression (rat), 103:296 in T-cell activation, 103:255 5-Aminolevulinic acid, in selective porphyrin accumulation in tumors (rat), 103:647 Aminopyrine breath test microsomal function and (rat), lO3:579 P300 Iatencies and, 103:302 Aminosalicylates, iron-chelatingproperties of, 103:1991-c 4-Aminosalicylic acid, for ulcerative colitis, 103:1706-c 5-Aminosalicylic acid in maintenance of remission in Crohn’s disease, 103:694-e nitric oxide role in neutrophil-mediated nitrosamine formation and (rat), 103:1260 Amplicon buildup, in polymerase chain reaction-e, 103:1098 Amylase perfusate bicarbonate conatamination by, 103:1174 somatostatin 28 effect on levels of, 103:240 Anal sphincter in fecal incontinence, 103:103 internal, nitric oxide in relaxation of (opossum), 103:43 Anemia, acute normovolemic, effects of on gastric mucosal blood flow (rat), 103:407 Aneuploidy, in chronic ulcerative 103:1602, 103:1611

colitis,

Angiotensin, in intestinal vascular response to hypotension (dog), lO3:57 Angiotensin II, in duodenal absorption of water and electrolytes (rat), 103:1568 Angulation, intestinal, jejunal unstirred layer and (rat), 103:1460 Antibiotics bactericidal, pancreatic of, 103:1902 surface hydrophobicity cosa in Helicobacter tion and, 103:1486

concentration of gastric mupylori infec-

Antibodies to complementary peptide to gastrin tetrapeptide, 103:749 ELAM-1, 103:840 to gliadin, 103:1517 to hepatitis C virus, 103:1108, 103:1285 to liver acetaldehyde adduct, 103:1860 (rat), 1969-e liver/kidney microsome type 1, 103:1290 in mixed cryoglobulinemia, 103:1108-ss monoclonal granulocyte recruitment in ischemia/reperfusion-induced intestinal dysfunction and (cat), 103:807

2024

SUBJECT INDEX

GASTROENTEROLOGY Vol. 103, No. 6

Lewis antigen expression in upper gastrointestinal epithelium assessed via, 103:1552 somatostatin (dog), 103:1221 polyclonal, anticyclo-oxygenase (rat), 103:1026 in prostaglandin deficiency (rabbit), 103:1467 to tenascin, 103:400 VCAM-1, 103:840 Antinucleating activity, for calcium carbonate, 103:552 Antioxidant defenses, in cholestasis (rats), 103:1625 Anti-neutrophil cytoplasmic antibodies, in relatives of patients with ulcerative colitis, 103:1706-c a,-Antitrypsin clearance, in sarcoidosis, 103:355-c Antrum, gastric aspirin effects on pathways of ion permeation in (Necturus), 103:1475 cCYP1A gene induction in by omeprazole, 103:1509 erythromycin effect on contraction of, in diabetic gastroparesis, 103:72 intravenous erythromycin overcomes small intestinal feedback on motility of, 103:114 APACHE II scores, in sterile pancreatic necrosis, 103:1636 Apnea, sleep, in irritable bowel syndrome, 103:12 Apoptosis early midzonal oxidative stress preceding, in hypopepfused liver (rat), 103:994 in rectal mucosa, in HIV infection, 103:919 AR4-ZJ cells, pituitary adenylate cyclase activating peptide effects on growth of (rat), 103:1002 Arachidonate, in gallstone 103:566

formation,

Arachidonic acid in lipopolysaccharide-stimulated Kupffer cells (rat), 103:1026 in rectal mucosal cell proliferation in subjects at risk for colon cancer, 103:883 D-Arginine, in failure to reverse suppressed internal anal sphincter relaxation (opossum), 103:43 L-Arginine, nitric oxide role in neutroPhil-mediated nitrosamine formation and (rat), 103:1260 Arginine vasopressin, in portal hypertension (rat), 103:235 Artemia S~&WJ, elongation factor 1 y in, 103:98 Asacol. See J-Aminosalicylic acid Ascites antenatal, in fatal neonatal liver failure in context of mitochondrial cytopathy, 103:1332-cr

cirrhosis with, thromboxane A, receptor blockade increases water diuresis in, 103:1017 in HBsAg-positive cirrhosis of the liver, 103:1630 malignant, mobilization of, 103:1302 renal insensitivity to atria1 natriuretic peptide in, 103:1710-c Ascorbic acid, nitric oxide role in neutrophil-mediated nitrosamine formation and (rat), 103:1260 Aspartate aminotransferase, serum, in HBsAg-positive cirrhosis of the liver, 103:1630 Aspirin cholesterol gallstones and, 103:1369-c in gastrointestinal bleeding, 103:862 ion permeation pathways in antrum affect by (Necturus), 103:1475 in leukocyte adhesion (rat), 103:146 Asthma, inflammatory bowel disease survival and mortality rates correlated with, 103:954 Atria1 natriuretic peptide (ANP), in cirrhosis, 103:601, 103:1710-c, 103:1996-c Atropine in cephalic stimulation, 103:383 in isometric contraction of terminal ileum (guinea pig), 103:29 N-[3H]methylscopolamine displacement by, 103:870 Autoantibodies neutrophil, 103:456, 103:1706-c in postpartum autoimmune gastritis, 103:934 Autoimmune gastritis classification of, 103:113, 103:1116, 103:1117-c in postpartum period and at 5-year follow-up, 103:934 Autoimmune hepatitis HLA class II molecules correlated with susceptibility to, 103:1041 liver/kidney microsome type 1 antibodies in, 103:1290 Autonomic nervous system, gut, in Crohn’s disease, 103:439 Autoradiography of w-3 fatty acid effect on rectal mucosal proliferation, 103:883 of somatostatin receptors in human lymphoid tissue, 103:1207 of transforming growth factor a receptor binding sites in gut (dog), 103:1427 Azathioprine, for pericrypt eosinophilic enterocolitis, 103:168 Azide, effect of on chemiluminescence of inflamed colonic mucosal scrapings (rat), 103:177

B-50 neuronal phosphoprotein, in HIV infection, 103:18 Backscattered electron imaging analysis, of Caco-2 cell mosaicism, 103:414

Bacteremia, in cirrhosis with gastrointestinal hemorrhage, norfloxacin in prevention of, 103:1267 Bacteria, in etiology of esophageal cancer, 103:1336-srr Bactericidal antibiotics, pancreatic concentration of, 103:1902 Bacterial colonization, differential induction of MHC molecules on intestine by (mouse), 103:1777 Bacterial formyl peptides, in epithelial permeability (rabbit), 103:1537 B and C receptors, glomerular, quantitative discrimination of, 103:1367-c Barium chloride in adenylate cyclase secretion, 103:539 reflux of into biliary ducts, 103:1709-c, 103:1989-c Barrett’s esophagus development of, 103:1241 flow cytometric assessment of regulatory peptides in, 103:1121-c Lewis antigen expression in, 103:1552 proliferating cell nuclear antigen in, 103:1769 Basement menbrane, colonic, tenascin in, 103:400 Basolateral membrane antral, effects of nutrient bicarbonate loss on resistance of (Necturus), 103:1475 hepatic, thiamine transport by (rat), 103:1056 intestinal, sodium transport in, 103:1817 of oxyntic glands, in postpartum autoimmune gastritis, 103:934 pancreatic, secretin effect on, 103:1674 BCECF dye, colonic mucosal intracellular pH and bicarbonate estimated using (rat), 103:120 B-cell lymphoma, immunoproliferative small intestinal disease associated with, 103:1071-cr Belch reflex, upper esophageal sphincter, in achalasia, 103:1574, 103:1685-e Bethanechol endotoxin effect on colonic transport function and (rat), 103:1437 in isometric contraction of terminal ileum (guinea pig), 103:29 in mucin and protein release in jejunum (rabbit), 103:496 Bicarbonate CAMP in duodenal mucosal secretion of, 103:153 in colonic chloride secretion (rat), 103:120 esophageal secretion of, 103:1174 nutrient, aspirin effect on ion permeation pathways in antrum and (Necturus), 103:1475 pancreatic secretion of, 103:1674-srr somatostatin 28 effect on pancreatic release of, 103:240 Bilateral cervical cooling blockade, vagal, in abolishment of gastric migrating motor complex (dog), 103:1491

December

1992

Bile composition, in prediction of gallstone calcification, 103:552 in gallstone formation, 103:566 in IgA receptor-mediated transport (rat), 103:296 lithogenic, after puberty, 103:636 secretion, cholylsarcosine effects on (rat), 103:1641 Bile acids anhepatic transport of (rat), 103:1034 in cell-mediated immunity impairment, 103:617 in esophagitis, 103:855 fecal, after bread ingestion, 103:1246 in migrating motor complexes (dog), 103:759 synthesis of cholylsarcosine effects on (rat), 103:1641 hepatic cholesterol metabolism in estrogen-treated men and, 103:1657 Bile salts iron excretion induced by (rat), 103:1707-c in isometric contraction of terminal ileum (guinea pig), 103:29 in weight reduction, 103:214 Biliary atresia, in neonates, 103:1022 Biliary colic, gallstones and, 103:311 Biliary ducts, reflux of air or barium into, 103:1709-c, 103:1989-c Biliary scintigraphy, of biliodigestive anastomosis (rat), 103:579 Biliary sludge, in acute pancreatitis, 103:1104-ss Biliary tree, in cystic fibrosis, 103:688-srr Biliodigestive anastomosis, reversibility of secondary biliary fibrosis by (rat), 103:579 Bilirubin in colon cancer, 103:448 in HBsAg-positive cirrhosis of the liver, 103:1630 in neonates, 103:660 Biomechanical wall properties, in partially obstructed esophagus (opossum), 103:1547 Biopsy, in routine management of ulcerative colitis, 103:431 2’,7’-bis(carboxyethyl)-5(and -6)carboxyfluorescein probe, in determination of pH, regulation in esophageal epithelial cells (rabbit), 103:830 Bismuth, surface hydrophobicity of gastric mucosa in Helicobacter pylori infection and, 103:1486 Blacks, Helicobacter pylori infection in, 103:813 Bleeding ulcers aspirin in, 103:862 injection therapy for, 103:1358-ss Blood alcohol levels, Hz-receptor antagonists and, 103:1102-ss Blood flow gastric, in cirrhosis, 103:1875 gastric mucosal, in anemia (rat), 103:407

SUBJECT INDEX

pancreatic, in chronic pancreatitis (cat), 103:652 Blood group-related antigens, metaplasia and, 103:1552 Blood pressure, sorbin and (rat), 103:1568 Bloody diarrhea, in septuagenarian, with jaundice and sepsis, 103:1349-cc Body mass index, high, in sterile pancreatic necrosis, 103:1636 Bombesin gastric acid and gastrin levels stimulated by, 103:1215 in HIV infection, 103:18 Book Reviews Advances in Drug Therapy of Gastroesophageal Reflux Disease (volume 20 in the Frontiers ofGastrointestinal Research series), 103:1112 Atlas of Gastroenterology, 103:1987 Basic Laboratory Methods in Medical Parasitology, 103:714 Clinical Nutrition for the House Officer, 103:349 Coeliac Disease: 40 Years Gluten-Free, 103:713 Gastrointestinal Pathology and Its Clinical Implications, 103:1704 Gluten-Sensitive Enteropathy (volume 19 in the Frontiers of Gastrointestinal Research series), 103:1987 Inflammatory Bowel Disease, 2nd ed. Unit 1 of the AGA Clinical Teaching Project updated, 103:1704 Peptic Ulcer Diseases: Unit 23 in the AGA Undergraduate Teaching Project, 103:348 The Stomach, 103:1365 Textbook of Internal Medicine. Volume 1, 2nd ed. Part III: Gastroenterology (pp 390-6731, 103:llll Therapy in Liver Disease, 103:1365 Trends in Inflammatory Bowel Disease Therapy, 103:713 Bowel habits, after right hemicolectomy, 103:794 Bowel transit time, slow, in colon cancer, 103:1783 Brain-gut interaction, irritable bowel syndrome as disorder of, 103:12 Bread ingestion, fecal bile acid pattern and, 103:1246 Breastmilk, effect of on feces and jaundice in neonates, 103:660 Bromobenzene, accelerated hepatocyte streaming and (rat), 103:1273 8-Bromo-cyclic adenosine monophosphate, pituitary adenylate cyclase activating peptide-induced AR4-2J cell growth not affected by (rat), 103:1002 Bromodeoxyuridine (BrdU), in assay of cell kinetics of gastric epithelium, 103:789 Bronchitis, inflammatory bowel disease survival and mortality rates correlated with, 103:954

2025

Brush border hydrolases, large bowel, 103:1452 Brush border membrane in Caco-2 cells, 103:414 in giardiasis (gerbil), 103:506 Buccal mucosa CYPlA gene induction in by omeprazole, 103:1509 in pyostomatitis vegetans, 103:668-cr Bumetanide, in adenylate cyclase secretion, 103:539 Butyrate enemas, for distal ulcerative colitis, 103:51 fecal content of after ileal pouch-anal anastomosis, 103:1144 for ulcerative colitis, 103:336-e BY 308 proton pump inhibitor, gastrin receptor antagonist effect on changes induced by (rat), 103:1596 Ca’+ -dependent agonist, endotoxin effect on colonic transport function and (rat), 103:1437 in esophagitis (cat), 103:1199 in gallbladder bile with weight reduction and gallstone formation, 103:214 in inflammatory diarrhea, 103:710-ss Caco-2 cells HDL,-retroendocytosis in, 103:469 mosaicism of, 103:414 Calcification, of gallstones, 103:552 Calcitonin gene-related peptide (C&RP), in HIV infection, 103:18 Calcium-binding protein, in ileal cholinergic longitudinal muscle motor neurons (guinea pig), 103:961 Calcium carbonate microspheroliths of, 103:552 precipitation, lithdstathine effect on, 103:1277 supplementation, decreases rectal epithelial cell proliferation in sporadic adenoma, 103:92 Calretinin, in ileal cholinergic longitudinal muscle motor neurons (guinea pig), 103:961 CAM 1189, effect of on endocrine cells during achlorhydria (rat), 103:1596 Canalicular bile formation, loss of due to hepatocyte dysfunction (rat), 103:1034 Canalicular cholestasis, major, in fatal neonatal liver failure in context of mitochondrial cytopathy. 103:1332cr Cancer, inflammatory bowel disease survival and mortality rates correlated with, 103:954 CAPANP cell line, lovastatin inhibition of growth of, 103:982 Carbachol in adenylate cyciase secretion, 103:539 m3 muscarinic receptor subtype and, 103:870

2026

SUBJECT INDEX

Carbohydrate malabsorption, in diarrhea, 103:545 Carbon tetrachloride, in induction of cirrhosis (rat), 103275 Carboxyl-terminal tetrapeptide, of gastrin, complementary peptide to, 103:749 Carcinoid diarrhea, scintigraphic colonic transit test in, 103:37 Cardiac index, endotoxin and platelet-activating factor effects on (rat), 103:282 L-Carnitine, for distal ulcerative colitis, 103:1710-c Case Reports Benign cartilaginous tumor (chondroma) of the liver, 103:678 Fatal neonatal liver failure and mitochondrial cytopathy: an observation with antenatal ascites, 103:1332 Glycerol interference in serum lipase assay falsely indicates pancreas injury, 103:1066 Hypersensitivity with hepatotoxicity to mesalazine after hypersensitivity to sulfasalazine, 103:1925 Immunoproliferative small intestinal disease in an American patient with lymphoma and macroamylasemia, 103:1071 Intermittent jaundice by tumor emboli from intrahepatic cholangiocarcinoma, 103:1669 Manometric characteristics of cervical dysphagia in a patient with the Kearns-Sayre syndrome, 103:1328 Menetrier’s disease associated with formula protein allergy and small intestinal allergy in an infant, 103:1664 Nonspecific esophageal motor disorder associated with thickened muscularis propria of the esophagus, 103:333 Paraneoplastic hepatopathy associated with soft tissue sarcoma, 103:330 Pyostomatitis vegetans and primary sclerosing cholangitis: markers of inflammatory bowel disease, 103:668 Successful dissolution of cholesterol gallstone during treatment with pravastatin, 103:1068 Successful treatment of a hepatic cyst by one-shot instillation of minocycline chloride, 103:675 Catalase, effect of on chemiluminescence of inflamed colonic mucosal scrapings, 103:177 (rat), 103:186 Catheter, in pharynx and transient lower esophageal sphincter relaxation, 103:1236 Cationic proteins, toxic, in eosinophilic gastroenteritis and celiac disease, 103:137 Caucasians, Helicobacter pylori infection in, 103:813

GASTROENTEROLOGY Vol. 103, No. 6

CAV cell line, lovastatin inhibition of growth of, 103:982 CD3+, in postpartum autoimmune gastritis, 103:934 CD4, gastrointestinal tract, in HIV infection, 103:18 Cefotaxime, pancreatic concentration of, 103:1902 Ceftizoxime, pancreatic concentration of, 103:1902 Celiac disease eosinophil granule major basic protein deposition in, 103:137 gliadin immune reactivity in, 103:1517 gluten-free diet in, 103:713-br overview of, 103:1987-br Cell differentiation, transforming growth factor (Yin, 103:1851 Cell kinetics, of gastric epithelium, 103:789 Cell-mediated immunity, 103:617

in cholestasis,

Cell membrane in acute necrotizing pancreatitis (opossum), 103:205 leucine transport across in cirrhosis, 103571 Cellular hyperplasia, of colonic mucosa, neurotensin-induced increase of (rat), 103:86 Cellular recognition events, complex, in acute inflammation, 103:1700-ss Central nervous system (CNS), arousal of, in irritable bowel syndrome, 103:12 Cephalic stimulation, of gastrointestinal secretory and motor responses, 103:383 Cerebrovascular disease, inflammatory bowel disease survival and mortality rates correlated with, 103:954 Cervical dysphagia, in Kearns-Sayre drome, 103:1328-cr Cervical vertebrae, pharyngeal relative to, 103:128

syn-

surfaces

Chelation, of iron, 103:1991-c Chemical agents, in etiology of esophageal cancer, 103:1336-srr Chemiluminescence assay, of reactive oxygen metabolite production in inflammatory bowel disease, 103:186, 103:77 Chemotactic peptide, gut permeability in response to (rabbit), 103:1537 Chenodeoxycholic acid, immunosuppressive effects of (mouse), 103:617 Cherry-red spots, in cirrhosis (rat), 103:1048 Chest pain angina-like, esophagus in, 103:1698-ss in nonspecific esophageal motor disorder with muscular hypertrophy, 103:333-cr Child-Pugh index, in HBsAg-positive cirrhosis of the liver, 103:1630

Children ileal resection/dysfunction in, 103:636 Indian childhood cirrhosis in, 103:1709C

Child’s classification, of cirrhosis, 103:595 Chloramines, histamine, gut permeability in response to (rabbit), 103:1537 Chloride fecal, in diarrhea, 103:545 in inflammatory diarrhea, 103:710-ss mucosal-to-serosal fluxes of in colon (rat), 103:781 pancreatic bicarbonate secretion and, 103:1674-srr secretion, intracellular bicarbonate in modulation of (rat), 103:120 sorbin effect on duodenal absorption of (rat), 103:1568 transport defect, in cystic fibrosis, 103:681-srr Cholangiocarcinoma, intrahepatic, intermittent jaundice by tumor emboli from, 103:1669-cr Cholangitis survival models for, 103:1893 ursodiol for, 103:343-ss Cholate, in anhepatic bile acid transport (rat), 103:1034 Cholecystectomy, for gallstones, 103:311 Cholecystokinin (CCK) in cephalic stimulation, 103:383 in contraction of gallbladder (guinea pig), 103:706-ss in gastric acid secretion and gastrin release, 103:356-c, 103:1215 in postprandial regulation of gastrin, 103:490 in isometric contraction of terminal ileum (guinea pig), 103:29 somatostatin 28 and, 103:240 Cholera toxin B, oral immunization against (mouse), 103:520 Cholescintigraphy, in acalculous colic, 103:1985-ss

biliary

Cholestasis antioxidant defenses in (rat], 103:1625 cell-mediated immunity in, 103:617 in fatal neonatal liver failure in context of mitochondrial cytopathy, 103:1332-cr opioids in (rat), 103:630 Cholesterol N-acetylcysteine and, 103:351-c cholylsarcosine and (rat), 103:1641 in estrogen-treated men, 103:1657 farnesyl as intermediate in synthesis of, 103:982 in gallbladder bile with weight reduction and gallstone formation, 103:214 in gallstone formation, 103:566 high-densitylipoproteinretroendocytosis and, 103:469 pravastatin in reduction of levels of, 103:1068-cr in puberty, 103:636

December

1992

SUBJECT INDEX

Choline acetyltransferase immunoreactivity, of ileal choline@ longitudinal muscle motor neurons (guinea pig), 103:961 Cholinergic system, in cephalic tion, 103:383

stimula-

Cholylsarcosine, physiological and regulatory effects of (rat), 103:1641 Chondroma, hepatic, 103:678-cr Chromatography, maturation 103:424

of procholecystokinin in intestine (rat),

Chronic gastritis, classification of, 103:1113-c, 103:1116-c, 103:1117-c Chronic segmental 103:1984-ss

colitis,

in elderly,

Chronic superficial injury, effects of on gastric mucosa (rat), 103:1179 Cigarette smoking, adenomatous tal polyps and, 103:1370-c Ciprofloxacin, pancreatic of, 103:1902

colorec-

concentration

Circadian rhythms, portal-systemic and (rat), 103:222

shunt

Cirrhosis amino acids in, 103:601 with ascites, thromboxane A, receptor blockade increases water diuresis in, 103:1017 atria1 natriuretic peptide in, 103:1710-c, 103:1996-c bacterial infection in, norfloxacin in prevention of, 103:1267 cytokines in, 103:264 defective platelet function in, 103:641 DNA synthesis increase in, 103595 endotoxin effects in (rat), 103:282 ethanol-induced gastric damage in (rat), 103:1048 in fatal neonatal liver failure in context of mitochondrial cytopathy, 103:1332-cr gastric blood flow in, 103:1875 HBsAg-positive, survival in, 103:1630 hepatocyte growth factor level in, 103:1621 HLA DRw8 and, 103:1118-c hyperdynamic circulation in, nitric oxide in modulation of, 103:1909 (rat1 IgA and interleukin 6 form positive secretory feedback loop in, 103:1296 Indian childhood, in an American child, 103:1709-c leucine and a-keto-isocaproic acid turnover in, 103:571 octreotide in, 103:229, 103:1992-c platelet-activating factor effects in (rat), 103:282 prognosis for, 103:1360-ss prostacyclin synthesis in, 103:1369-c somatostatin renal effects in, 103:1868 vascular capacity in (rat), 103:275 visual event-related P300 potentials in, 103:302

c-K-ras gene mutations, during colon cancer in familial adenomatous polyposis, 103, 103:1725 “Cl absorption, colonic, endotoxin-induced alteration in (rat), 103:1437 Clearance force, esophageal, in esophagitis, 103:943 Clinical Challenges Bloody diarrhea, jaundice, and sepsis in septuagenarian, 103:1349 Clinical nutrition, for house officers, 103:349-br Clostridium dificile colitis, surgical abdomen due to, 103:355-c c-myc protooncogene, in colon cancer (mouse), 103:1823 Coagulation factors, in HBsAg-positive cirrhosis of the liver, 103:1630 Cognitive dysfunction, in cirrhosis, 103:302 Colitis antineutrophil cytoplasmic autoantibodies in relatives of patients with, 103:1706-c L-carinitine for, 103:1710-c chronic diarrhea and, 103:168 colon cancer risk and mortality in, 103:1444 cytokine messenger RNA profiles in, 103:1587 dysplasia development in, 103:1611 in elderly, 103:1984-ss epidemiology of, 103:696-e familial aggregation of, 103:514 fish oil for, 103:1096-e low-grade dysplasia and cancer in, 103:431 lysozyme gene expression in, 103:532 neoplastic progression in, 103:1602 neutrophil autoantibodies in, 103:456 reactive oxygen metabolites in, 103:177 (rat), 103:186 short-chain fatty acids in, 103:336-e subepithelial collagen table thickness in, 103:1790 survival and causes of death in, 103:954 tenascin in, 103:400 vascular adhesion molecules in, 103:840 Collagen, in partially obstructed esophagus (opossum), 103:1547 Collagen table thickness, subepithelial, in microscopic/collagenous colitis, 103:1790 Collagenous colitis chronic diarrhea and, 103:168 subepithelial collagen table thickness in, 103:1790 Colon angiotensin role in intestinal vascular response to hypotension in, 103:57 butyrate enema effects on, 103:51 cancer chronic inflammation in, 103:1260 dietary fiber and, 103:1783, 1964-e drug metabolizing enzymes in, 103:448

2027

elongation factor 1 -r-related RNA in, 103:98 in familial adenomatous polyposis, 103, 103:1725 fecal bile acids in, 103:1246 fish oil and, 103:883, 103:1096-e hemicolectomy for, 103:794 hypergastrinemia correlated with, 103:1361-ss inflammatory bowel disease survival and mortality rates correlated with, 103:954 mosaicism in, 103:414 ornithine decarboxylase expression in, 103:1823 (mouse) P-170 glycoprotein in, 103:448 and primary sclerosing cholangitis in ulcerative colitis, 103:1707-c proliferating cell nuclear antigen expression in (rat), 103:160 surveillance in routine management of ulcerative colitis and, 103:431 tenascin in, 103:400 ulcerative colitis and, 103:1444 CYPlA gene induction in by omeprazole, 103:1509 dysplasia in, 103:1602, 1611 endotoxin-induced alterations in water and electrolyte transport in, 103:1437 intracellular bicarbonate in modulation of chloride secretion in (rat), 103:120 mucosa, neurotensin-induced growth of (rat), 103:86 polyps, smoking and, 103:1370-c propulsion of contents of after eating, 103:72 prostaglandin D, in inhibition of neuronally mediated secretion of (rat), 103:781 short-chain fatty acids in, 103:336-e solitary lymphatic follicles, somatostatin receptors in, 103:1207 transit lactulose-induced acceleration of, 103:1167 right and left, after eating, 103:80 scintigraphy of, 103:37 transverse, transforming growth factor a receptor binding sites in, 103:1427 vascular cell adhesion molecule expression in, 103:840 Colonoscopy surveillance, of ulcerative colitis, 103:431 Columnar epithelium, in Barrett’s esophagus, 103:1241 Computed tomography (CT), of chondroma, 103:678-cr Connective tissue disease, pericrypt eosinophilic enterocolitis and, 103:168 Constipation, idiopathic, scintigraphic colonic transit test in, 103:37 Copper/zinc superoxide dismutase (CuZnSOD), in cellular protection against free radicals, 163:965

2028 SUBJECT INDEX

Correspondence N-Acetylcysteine is useless for oral gallstone dissolution, 103:351 Anti-neutrophil cytoplasmic autoantibodies in relatives of patients with ulcerative colitis, 103:1706 Atria1 natriuretic factor in experimental cirrhosis, 103:1996 Bile salt-induced excretion of iron in iron-loaded rats, 103:1707 L-Carnitine for treatment of distal ulcerative colitis, 103:1710 Cholecystokinin exerts a tonic inhibitory influence on gastric acid secretion and gastrin release, 103:356 Cholesterol gallstones and aspirin, 103:1369 Determinants of portal hypertensive gastropathy reconsidered, 103:1990 Different iron-chelating properties of aminosalicylates, 103:1991 Does erythromycin really have a prokinetic effect on the gallbladder?, 103:1995 Duodenal cancer in polyposis patients, 103:1995 Effect of age and sex on hepatic intracinar enzyme profile, 103:351 Enteric protein losing in sarcoidosis, 103:355 Flow-cytometric assessment of regulatory peptides in Barrett’s mucosa, 103:1121 Grading and classification of chronic gastritis, 103:1116 Hemodynamics of octreotide in hepatitis B-related cirrhosis, 103:1992 Hepatotoxicity associated with piroxicam use, 103:354 Histological classification of chronic gastritis: an iconoclastic view, 103:1117 HLA DRw8 and primary biliary cirrhosis, 103:1118 Indian childhood cirrhosis in an American child, 103:1709 Influence of myenteric neuronal denervation on epithelial cell proliferation, 103:1122 Interleukin-6 production in Crohn’s disease, 103:1120 Is prostacyclin synthesis greater in cirrhotic patients?, 103:1369 Lipase/amylase ratio in pancreatitis: an etiologic index?, 103:353 The lipase/amylase ratio: sensitive but not specific, 103:352 Malabsorption secondary to intestinal hurry, 103:1995 Malignant degeneration of esophageal squamous papilloma associated with the human papillomavirus, 103:1119 Manometry in classic and vigorous achalasia, 103:1993 Nutritional therapy for alcoholic hepatitis, 103:357

GASTROENTEROLOGY Vol. 103,No.6

Oral 4-aminosalicylic acid therapy in ulcerative colitis, 103:1706 Quantitative distribution of glomerular B and C receptors, 103:1367 Reflux of air or barium into the biliary ducts, 103:1709, 103:1989 Relationship between colorectal neoplasia and primary sclerosing cholangitis in ulcerative colitis, 103:1707 Renal insensitivity to atria1 natriuretic peptide in patients with cirrhosis and ascites, 103:1710 The role of gastric secretagogues in regulating gastric histamine release in vivo, 103:1123 Selective bowel decontamination and liver regeneration, 103:1993 Septicemia after endoscopic retrograde cholangiopancreatography, 103:1367 Smoking and adenomatous colorectal polyps, 103:1370 Some German remarks on ‘One American response to the Sydney system’, 103:1113 Statistical analysis of crossover studies, 103:1994 Surgical abdomen due to Clostridium dificile-induced colitis, 103:355 The Sydney system and chronic gastritis, 103:1113 Corticosteroids for autoimmune hepatitis, 103:1290 for pericrypt eosinophilic enterocolitis, 103:168 C-reactive protein (CRP), in chronic liver disease, 103:264 Creatinine kinase isoenzymes, in diagnosis of intestinal infarction, 103:1106-ss %r-EDTA granulocyte recruitment in ischemia/ reperfusion-induced intestinal dysfunction and (cat), 103:807 gut permeability to (rabbit), 103:1537 Crohn’s disease 5-aminosalicylic acid for, 103:363 cytokine messenger RNA profiles in, 103:1587 elemental vs. polymeric diet for, 103:1363-ss epidemiology of, 103:392, 103:696-e familial aggregation of, 103:514 fish oil for, 103:1096-e interleukin-6 production in, 103:1120-c lysozyme gene expression in, 103:532 maintenance of remission in, 103:694-e mesalazine for, 103:1925-cr MHC class II antigens on enteroglial cells in, 103:439 reactive oxygen metabolites in, 103:186 sulfasalazine for, 103:1925-cr survival and causes of death in, 103:954 vascular adhesion molecules in, 103:840 Crossover studies, statistical analysis of, 103:1994-c

Cryoglobulinemia, mixed, antibodies to hepatitis C virus in patients with, 103:1108-ss Crypt hyperplasia in giardiasis (gerbil), 103:506 as index of proliferating cell nuclear antigen (rat), 103:160 Cyclic adenosine monophosphate (CAMP) in colonocyte ion transport, 103:539 in duodenal mucosal bicarbonate secretion, 103:153 in lower esophageal sphincter circular muscle (cat), 103:1199 pancreatic bicarbonate secretion and, 103:1674-srr Cyclic guanosine monophosphate (cGMP), in lower esophageal sphincter circular muscle (cat), 103:1199 Cycle-oxygenase, fatty acid, induction in Kupffer cells (rat), 103:1026

of

Cycle-oxygenase inhibitor, antioxidant, effect of on chemiluminescence of inflamed colonic mucosal scrapings (rat], 103:177

CYPIA genes, omeprazole in induction of, 103:1509 Cystic fibrosis scientific advances in, 103:681-srr transmembrane conductance regulator, pancreatic bicarbonate secretion and, 103:1674+rr Cysts, hepatic, minocycline 103:675-cr

chloride

for,

Cytochrome c oxidase defect, in fatal neonatal liver failure in context of mitochondrialcytopathy,lO3:1332cr Cytochrome P-450 after biliodigestive anastomosis (rat), 103:579 in colon cancer, 103:448 genes, omeprazole in induction of, 103:1509 in methylbenzylnitrosamine activation (rat), 103:800 Cytokines in acute-phase induction of manganese superoxide dismutase in intestinal epithelial cell lines, 103:905 in chronic liver disease, 103:264 fibronectin synthesis in Ito cell regulated by (rat), 103:1313 mRNA profiles of in inflammatory bowel disease detected by PCR, 103:1587 Cytomegalovirus (CMV) in etiology of esophageal cancer, 103:1336-srr in livers of infants with neonatal hepatitis, 103:1022 polymerase chain reaction in detection of, 103:1098-e in posttransplant hepatitis, 103:317

December

1992

SUBJECT INDEX

[D-Ala,Met]-enkephalinamide (DAMA), in duodenal absorption of water and electrolytes (rat), 103:1568 [3H]-DAMG0 opiate receptor ligand, total plasma opioid activity and (rat), 103:630

Deglutitive inhibition, primary esophageal peristalsis and, 103:876 Deglutitive pharyngoesophageal function, in Kearns-Sayre syndrome, 103:1328-cr Denervation, myenteric neuronal, effect of on epithelial cell proliferation, 103:1122-c Denmark, colon cancer risk and mortality in patients with ulcerative colitis in, 103:1444 Densitometry, of transforming growth factor (Yreceptor binding sites in gut (dog), 103:1427 Deoxycholic acid, bread ingestion 103:1246

and,

Desquamation, in mesalazine hypersensitivity reaction, 103:1925-cr Dextrose, intraduodenal, adaptive changes in pyloric motor response after, 103:1754 Diabetic gastroparesis, erythromycin effects on gastric motility in, 103:72 2,3-Diaminonapthlene, nitric oxide role in neutrophil-mediated nitrosamine formation and (rat), 103:1260 Diarrhea bloody, in septuagenarian, with jaundice and sepsis-cc, 103:1349 endotoxin effect on colonic transport function and (rat), 103:1437 in food allergy, 103:1075-srr in giardiasis (gerbil), 103:506 mechanisms of, 103:710-ss in mesalazine hypersensitivity reaction, 103:1925-cr osmotic distinguished from secretory, 103:545 osmotic gap and, 163:702-e in pericrypt eosinophilic enterocolitis, 103:168 scintigraphic colonic transit test in, 103:37 Dichlorofluorescein diacetate, in assay of early midzonal oxidative stress preceding apoptosis in hypoxic liver (rat), 103:994 Diet, effect of on feces and jaundice neonates, 103:660

in

Digital microfluorography, of early midzonal oxidative stress preceding apoptosis in hypoxic liver (rat), 103:994 Dimethylhydrazine, proliferating cell nuclear antigen expression in colon tumors induced by (rat), 103:160 l,l-Dimethyl-4-phenylpiperazinium, in internal anal sphincter relaxation (opossum), 103:43

Dimethyl sulfoxide (DMSO), effect of on chemiluminescence of inflamed colonic mucosal scrapings, 103:186 Dipeptides, glutamine uptake from, 103:3 Dipeptidyl peptidase IV, in neoplastic and hyperplastic large bowel lesions, 103:1452 Distal esophageal banding, biomechanical wall properties and collagen content in partially obstructed esophagus and (opossum), 103:1547 Diuretics, mobilization of malignant ascites with, 103:1302 DNA aneuploidy, in chronic ulcerative colitis, 103:1602, 1611 in chronic ulcerative colitis, 103:1602, 1611 in colonic mucosa, neurotensin-induced increase of (rat), 103:86 in hepatocytes from cirrhotic tissue, correlated with liver cancer development, 103:595 Docosahexenoic acid (DHA), colon cancer and, 103:1096-e Dogiel type morphology, of ileal cholinergic longitudinal muscle motor neurons (guinea pig), 103:961 Dual isotopic technique, in assessment of right and left colonic transit, 103:80 Dukes’ classification, for colon cancer, 103:98 Duodenum absorption, sorbin effect on (rat), 103:1568 adrenergic blockade and (dog), 103:1491 bicarbonate secretion in, 103:153 cancer, in familial adenomatous polyposis, 103:1995-c cephalic stimulation of, 103:383 CYPlA gene induction in by omeprazole, 103:1509 dextrose infusion in, adaptive changes in pyloric motor response after, 103:1754

in gallstone formation, 103:566 in giardiasis (gerbil), 103:506 injury, spectrum of produced by perfusion with luminal acid (rat), 103:481 Lewis antigen expression in, 103:1552 migrating motor complexes in, enterohepatic circulation essential for regular cycling of (dog), 103:759 motility, intravenous erythromycin overcomes small intestinal feedback on, 103:114 ontogeny of procholecystokinin maturation in (rat), 103:424 peptides, in HIV infection, 103:18 transforming growth factor 01receptor binding sites in, 103:1427 tryptophan administration in, 103:240 ulcer aspirin in, 103:862 Helicobacter pylori eradication in reduction of, 103:1695ss omeprazole for, 103:913

2029

periodicity of, 103:1192 surface hydrophobicity of gastric mucosa in, 103:1486 Dynamic anal manometry, of fecal incontinence, 103:103 Dyspepsia chronic idiopathic, Helicobacter pylori and gastric emptying in, 103:768 non-ulcer, Helicobacter pylori in, 103:340-ss Dysphagia in Kearns-Sayre syndrome, 103:1328-cr in nonspecific esophageal motor disorder with muscular hypertrophy, 103:333-cr in Zenker’s diverticulum, 103:1229 Dysplasia, in ulcerative colitis, 103:431, 103:1602. 103:1611 Early portosystemic encephalopathy, visual event-related P300 potentials in, 103:302 Eating colonic propulsive effect of, 103:80 somatostain 28 released from gut during, 103:240 ED1 positive sequences, specific for fibronectin (rat), 103:1313 Edema, colonic, IL-lra effect on levels of (rabbit), 103:65 Editorials The beneficent belch, 103:1685 Colonic short-chain fatty acids: fuel from the lumen? 103:336 The epidemiology of inflammatory bowel disease: are we learning anything new? 103:696 Farther, faster and (hopefully) better! 103:1099 Fiber and colon cancer: the weight of the evidence, 103:1964 Fish oil and colon cancer, 103:1096 The gastroenterologist’s osmotic gap: fact or fiction, 103:702 Hepatitis B after liver transplantation: new names for unusual presentations, 103:1355 Hepatitis B-related end-stage liver disease, 103:1692 Hepatitis C viral infection in liver transplant patients: how bad is it really?, 103:338 Hepatocyte growth factor-how do I know thee? Let me count the ways, 103:1686 Immune responses to acetaldehydeprotein adducts: role in alcoholic liver disease, 103:1969 Maintenance of remission in Crohn’s disease: is 5’-aminosalicylic acid the answer?, 103:694 Oral carrier vaccines: new tricks in an old trade, 103:699 Pacing the gut, 103:1967 Polymerase chain reaction for the detection of hepatitis viruses: panacea or purgatory?. 103:1098

2030

GASTROENTEROLOGY

SUBJECT INDEX

Somatostatin and portal hypertensive bleeding: a safe therapeutic alternative?, 103:1973 Edrophonium, in increased esophageal motility and lower esophageal sphincter pressure, 103:775 Eicosapentaenoic acid (EPA), colon cancer and, 103:883, 103:1096-e Elderly bloody diarrhea, jaundice, and sepsis in, 103:1349-cc chronic segmental colitis in, 103:1984-ss Electrolytes in chronic diarrhea, 103:702 colonic transport of, endotoxin-induced alterations in (rat), 103:1437 sorbin effect on duodenal absorption of (rat), 103:1568 Electromyographic recording, of pharyngeal catheter effect on lower esophageal sphincter relaxation, 103:1236 Electronic strain gauge, attached to inflatable balloon, in identification of abnormal esophageal clearance response to intraluminal distension, 103:943 Electron microscopy of acute necrotizing pancreatitis (opossum), 103205 aspirin effect on ion permeation pathways in antrum and (Necturus), 103:1475 of fatal neonatal liver failure in context of mitochondrial cytopathy-cr. 103:1332 of high-density lipoprotein retroendocytosis, 103:469 Elemental diet, for Crohn’s disease, 103:1363-ss Elongation factor 1 y, expression of in colon cancer, 103:98 Embryogenesis, tenascin in, 103:400 Emphysema, inflammatory bowel disease survival and mortality rates correlated with, 103:954 Emptying, gastric in dyspepsia, Helicobacter pylori in, 103:768 after gastric surgery and with pacing, 103:1811 magnetic resonance imaging of, 103:369 after right hemicolectomy, 103:794 Encephalopathy early portosystemic, visual event-related P300 potentials in, 103:302 in HBsAg-positive cirrhosis of the liver, 103:1630 Endocrine cells, during achlorhydria, gastrin receptor blockade effect on (rat), 103:1596 Endocrine tumors, pancreatic, 103:1982-ss Endoscopic injection, for bleeding ulcers, 103:1358 Endoscopic retrograde cholangiopancreatography, septicemia after, 103:1367-c

Endoscopic ultrasonography of islet cell tumors, 103:711-ss of nonspecific esophageal motor disorder with muscular hypertrophy, 103:333-cr Endothelial cells, in HIV infection, 103:919 Endothelial leukocyte adhesion molecule l(ELAM-l), in inflammatory bowel disease, 103:840 Endotoxin hemodynamic effects of in cirrhosis (rat), 103:282 in intestinal transport (rat), 103:1437 Enteral nutrition for Crohn’s disease, 103:1363-ss metabolic effects of long-term ethanol consumption and [rat), 103:289 Enteric protein losing, in sarcoidosis, 103:355-c Enterochromaffinlike cells during achlorhydria, gastrin receptor blockade effect on (rat), 103:1596 histamine-depleted, hyperplasia of (rat), 103:897 Enterocolitis, chronic diarrhea and, 103:168 Enterocytes in giardiasis (gerbil), 103:506 HDL,-retroendocytosis in, 103:469 Enterogastrone, somatostatin as (dog), 103:1221 Enteroglial cells, in Crohn’s disease, MHC class II antigens on, 103:439 Enteroglucagons, plasma, in adaptive bowel growth after jejunoileal resection, 103:462 Enterohepatic circulation, in regular cycling of duodenal migrating motor complexes (dog), 103:759 Enteropathy, overt and latent, in relatives of celiac patients, 103:1517 Enzyme-linked immunosorbent assay (ELISA) of anti-HBc status, 103:590 of neutrophil autoantibodies in ulcerative colitis, 103:456 of ~24 protein in rectal mucosa, 103:919 of pig receptor expression by hepatocytes (rat), 103:296 Enzymes, drug-metabolizing, expression of in colon cancer, 103:448 Eosinophil granule major basic protein, in eosinophilic gastroenteritis and celiac disease, 103:137 Eosinophils, in rectal mucosa in HIV infection, 103:919 Epidemiology of Crohn’s disease, 103:392 of inflammatory bowel disease, 103:696-e Epidermal growth factor (EGF), in Barrett’s esophagus, 103:1121-c Epinephrine in adrenergic modulation of interdigestive pancreatic secretion, 103:990 in portal hypertension (rat), 103:235

Vol. 103, No. 6

Epithelial cells in Barrett’s esophagus, 103:1769 colonic, mucosal hydrolases in, 103:1452 gastric, adaptive cytoprotection in (rat), 103:1179 intestinal, acute-phase induction of manganese superoxide dismutase in, 103:905 myenteric neuronal denervation influence on proliferation of, 103:1122-c in postpartum autoimmune gastritis, 103:934 rectal, calcium-induced decrease in proliferation of, 103:92 villus, lactase gene expression during early development of (rat), 103:1154 Epithelial sloughing, in cirrhosis (rat), 103:1048 Epstein-Barr virus (EBV), in etiology of esophageal cancer, 103:1336-srr Erythema, generalized, in cirrhosis (rat), 103:1048 Erythromycin in gallbladder motility, 103:1995-c in gastric motility in diabetic gastroparesis, 103:72 intravenous, overcomes small intestinal feedback on gastrointestinal motility, 103:114 Esophageal manometry of esophageal motility, 103:775 of lower esophageal sphincter, 103:377 Esophageal motor disorder, muscular hypertrophy associated with, 103:333cr Esophageal squamous papilloma, malignant degeneration of, human papillomavirus associated with, 103:1119-c Esophagitis acute experimental, impairs signal transduction in lower esophageal sphincter circular muscle (cat), 103:1199 esophageal clearance force in, 103:943 gastric acidity and gastroesophageal reflux in, 103:855 Esophagus in achalasia, 103:377, 103:1574, 103:1685-e bicarbonate secretion in, 103:1174 cancer Barrett’s esophagus and, 103:1241 infectious agents in etiology of, 103:1336-srr methybenzylnitrosamine-induced (rat), 103:800 ~53 gene mutations in, 103:892 cultured epithelial cells, pHi regulation in [rabbit), 103:830 CYPlA gene induction in by omeprazole, 103:1509 distal, salivary secretion modulated by acid infusion in, 103:1833 emptying, impedance effect on (cat), 103:708-ss in Kearns-Sayre syndrome, 103:1328-cr

December

1992

Lewis antigen expression in, 103:1552 motility, acute hyperglycemia effect on, 103:775 in noncardiac chest pain, 103:1698-ss partially obstructed, biomechanical wall properties and collagen content in (opossum), 103:1547 peristalsis, wave of inhibition precedes, 103:876 in pharyngeal clearance during swallowing, 103:128 sensory innervation of (cat), 103:817 transforming growth factor (Yreceptor binding sites in, 103:1427 Estradiol, effect of on ornithine decarboxylase expression in colon cancer, 103:1823 (mouse) Estrogen, for metastatic prostate cancer, effects of on hepatic cholesterol metabolism, 103:1657 Ethanol blood levels, HZ-receptor antagonists and, 103:1102-ss gastric damage induced by in cirrhosis (rat), 103:1048 liver triglycerides and protein metabolism affected by (rat), 103:289 Ethoxyresorufin, deethylation of, in assessment of p450-dependent enzymatic activity, 103:1509 Extracellular matrix glycoproteins, synthesis of in Ito cells (rat), 103:1313 Extracorporeal shock-wave lithotripsy, and ursodiol vs. ursodiol alone for gallstones, 103:311 Extrahepatic obstruction, biliary cirrhosis as complication of (rat), 103:579

Familial adenomatous polyposis colon cancer in, c-K-ras gene mutations during, 103, 103:1725 duodenal cancer with, 103:1995-c Familial aggregation of inflammatory bowel disease, 103:514 of ulcerative colitis, 103:456 Family history, of Crohn’s disease, 103:392 Farnesyl, in RAS protein activation, 103:982 Fast blue, in retrograde labeling of sensory cell bodies, 103:817 Fasting, right and left colonic transit after, 103:80 Fat, intestinal, in inhibition of gastric function (dog), 103:1221 Fecal fluid, osmotic gap of, 103:545 Fecal incontinence, dynamic anal manometry of, 103:103 Fecal weight, in colon cancer, 103:1783 Feces lysozyme levels in, 103:532 neonatal, effect of diet on, 103:660 short-chain fatty acids in, after ileal pouch-anal anastomosis, 103:1144 Feeding readiness, of neonates, manometry in prediction of, 103:1523

SUBJECT INDEX

Ferrocheletase, in liver metastases (rat), 103647 Fever, in mesalazine hypersensitivity reaction, 103:1925-cr Fiber, dietary, colon cancer and, 103:1783, 1964-e Fibroblasts, tenascin produced from, 103:400 Fibronectin synthesis of in lto cells (rat), 103:1313 tenascin as antagonist of, 103:400 Fibrosing cytolytic liver failure, secondary to recurrent hepatitis B after liver transplantation, 103:1307 Fibrosis, secondary biliary, reversibility of by biliodigestive anastomosis (rat), 103:579 Finland, fecal bile acid profiles in after bread ingestion, 103:1246 Fish oil colon cancer and, 103:1096-e in rectal mucosal cell proliferation in subjects at risk for colon cancer, 103:883 Fistulas, neurotensin effect on gut mucosal growth and (rat), 103:1254 Flow cytometry of cell kinetics of gastric epithelium, 103:789 of regulatory peptides in Barrett’s esophagus, 103:1121-c Fluorescein isothiocyanate (FITC)-labeled IgG fractions, in immunohistochemical detection of hepatitis C virus antigen (chimpanzee, humans), 103:622 Fluorescent probe, in determination of pHi regulation in esophageal epithelial cells (rabbit), 103:830 Fluorochrome, in assay of early midzonal oxidative stress preceding apoptosis in hypoxic liver (rat), 103:994 Fluorography, of pig receptor expression by hepatocytes (rat), 103:296 a-Fluoromethylhistidine, in hyperplasia of histamine-depleted enterochromaffinlike cells in stomach (rat), 103:897 Food hypersensitivity, gastrointestinal, basic mechanisms of pathophysiology, 103:1075-srr Food intake. See Eating Formalin-immune complex colitis, IL-lra in blocking proinflammatory activity of endogenous interleukin-1 in (rabbit), 103:65 Formula, infant effect of on feces and jaundice in neonates, 103:660 Menetrier’s disease associated with allergy to, 103:1664-cr Formyl-methionyl-leucyl-phenylalanine (fMLP), luminal, in epithelial permeability (rabbit), 103:x537 Frame shift mutations, p53 gene, in gastric and esophageal cancers, 103:892

2031

Free radicals in hypoxic liver (rat), 103:994 superoxide dismutases in reduction of, 103:905 Free-floating tumor debris, from intrahepatic cholangiocarcinoma, intermittent jaundice by, 103:1669-cr Fundus, gastric, Lewis antigen expression in, 103:1552 Fungi, in etiology of esophageal cancer, 103:1336-srr Gadolinium tetraazacyclododecane tetraacetic acid, as marker in MRI of gastric emptying, 103:369 Galactose elimination capacity I?300 latencies and, 103:302 in primary biliary cirrhosis, 103:1360-ss Galanin, in HIV infection, 103:18 Gallbladder cholecystokinin in contraction of (guinea pig), 103:706-ss motility, erythromycin in, 103:1995-c Gallstones N-acetylcysteine for, 103:351-c in acute pancreatitis, 103:1104-ss aspirin and-c, 103:1369 after estrogen therapy for metastatic prostate cancer, 103:1657 extracorporeal shock-wave lithotripsy and ursodiol vs. ursodiol alone in treatment of, 103:311 formation of, 103:566 pravastatin for, 103:1068-cr prediction of calcification of, 103:552 after puberty, 103:636 weight reduction and, 103:214 Gamma camera scintigraphy, of gastric emptying, 103:369 Gastric acid in gastric ulcers in prostaglandin-deficient conditions (rabbit), 103:1467 secretion cholecystokinin in, 103:356-c loxiglumide in, 103:1215 Gastric body, CYPIA gene induction in by omeprazole, 103:1509 Gastric gland luminal pressure, acid secretion in (rat), 103:1797 Gastric mucosal barrier, uremia effects on (rat), 103:1762 Gastric mucosal blood flow, anemia and (rat), 103:407 Gastric mucosal perfusion, increased, in cirrhosis with portal hypertensive gastropathy, 103:1875 Gastric remnant, cell kinetics of, 103:789 Gastrin cephalic stimulation and, 103:383 cholecystokinin in release of, 103:356-c, 103:490 in colon cancer, 103:1361-ss complementary peptide to the carboxyl-terminal tetrapeptide of, 103:749 histamine-depleted enterochromaffinlike cell response to (rat), 103:897

2032

SUBJECT INDEX

loxiglumide effect on secretion of, 103:3215 in postpartum autoimmune gastritis, 103:934 receptor blockade, effect of on endocrine cells during achlorhydria (rat), 103:1596 Gastritis classification of, 103:1113-c, 1116-c, 1117-c Helicobacter pylori in (piglet), 103:1580 in postpartum period and at 5-year follow-up, 103:934 Gastrocnemius muscle, protein content, ethanol effects on (rat), 103:289 Gastroenterology, atlas of, 103:1987-br Gastroesophageal retlux advances in drug therapy for, 103:1112br esophageal clearance force in, 103:943 in esophagitis, 103:855 intensive therapy for, 103:1696-ss Gastrointestinal pathology, clinical implications of, 103:1704-br Gastrointestinal practice and education, future of, 1013:1715 Gastropancreatic secretion, cephalic stimulation and, 103:383 Gastroparesis motility patterns in, 103:72, 114 testing drugs for, 103:705-ss Gel electrophoresis, of pancreatic juice, 103:248 Gender, effect of on hepatic intracinar enzyme profile, 103:351-c Genes brush border enzyme, 103:1529 cholecystokinin (rat), 103:424 CYPlA, 103:1509 cystic fibrosis, 103:683-srr gro, 103:1587 K-ras, 103:982 lactase, 103:1154 lysozyme, 103:532 m3 muscarinic receptor subtype, 103:870 ~53, 103:892 yop, 103:520 Genetic heterogeneity, in ulcerative colitis, 103:456 Genome, cytomegalovirus, 103:1022 Genomic variation, of hepatitis C virus, 103:344-ss Germinal centers, of human gut lymphoid tissue, somatostatin receptors in, 103:1207 Giardiasis, pathogenesis of (gerbil), 103:506 Gliadin immune reactivity, overt and latent enteropathy in relatives of celiac patients correlated with, 103:1517 Glomerular B and C receptors, quantitative discrimination of, 103:1367-c Glucagon, in cirrhosis, 103:601 Glucose actively transported, in boosted muco-

GASTROENTEROLOGY Vol. 103, No. 6

sal immune responsiveness (rat), 103:1162 blood levels, effect of on esophageal motility, 103:775 in jejunal unstirred layer, 103:1460 Glucose/galactose malabsorption, caused by defect in Na/glucose cotransporter, 103:1105-ss Glutamine-dipeptide, absorption in human intestine, 103:3 Glutathione peroxidase, in obstructive jaundice (rat), 103:1625 Glutathione S-transferase in colon cancer, 103:448 in obstructive jaundice (rat), 103:1625 Gluten-sensitive enteropathy. See Celiac disease Glycerol interference, in serum lipase assay, 103:1066-cr Glycodeoxycholate, in isometric contraction of terminal ileum (guinea pig), 103:29 Glycoproteins in gallstone formation, 103:566 synthesis of in Ito cells (rat), 103:1313 Glycoursodeoxycholate, in isometric contraction of terminal ileum (guinea pig), 103:29 Glycylglutamine, absorption of, in human intestine, 103:3 GMP-40, expression of by endothelium stimulated by histamine or thrombin, 103:1700-ss G protein mitogenic effect, of pituitary adenylate cyclase, activating peptide dependent on (rat), 103:1002 Grains, in etiology of esophageal cancer, 103:1336-srr Gram-negative bacilli, in cirrhosis, norfloxacin prevents infections due to, 103:1267 Granulocyte-derived chlorinated amines, in epithelial permeability (rabbit), 103:1537 Granulocyte recruitment, in ischemia/ reperfusion-induced intestinal dysfunction (cat), 103:807 Granulomas, lysozyme synthesis in, 103:532 gre gene, mRNA profile of in inflammatory bowel disease detected by PCR, 103:1587 Guanosine triphosphate (GTP), somatostatin receptors in human gut lymphoid tissue and, 103:1207 Guar gum, in accelerated proximal colon transit, 103:1167 Gut eosinophil degradation of, 103:137 food allergy and, 103:1075-srr lymphoid tissue, somatostatin receptors in, 103:1207 permeability, in response to histamine chloramines and chemotactic peptide (rabbit), 103:1537 somatostatin 28 released from during food intake, 103:240

transforming growth factor (Yreceptor binding sites in (dog), 103:1427 H+,K+-adenosine triphosphatase, parietal cell antibodies specific against, in postpartum autoimmune gastritis, 103:934 HZ-receptor antagonists, blood alcohol levels and, 103:1102-ss H,O, scavenger, effect of on chemiluminescence of inflamed colonic mucosal scrapings (rat], 103:177 H2T cell line, lovastatin inhibition of growth of (hamster), 103:982 Helicobacter pylori gastritis chimpanzee model of (baboon, chimpanzee], 103:848 chronic active (piglet), 103:1580 classification of, 103:1113-c, 1116-c eradication of reduces gastric and duodenal ulcer occurrence, 103:1695-ss gastric emptying in dyspepsia and, 103:768 in Hispanics, Blacks, and Caucasians, 103:813 in non-ulcer dyspepsia, 103:340-ss in phagocyte oxidative metabolism, 103:1747 surface hydrophobicity in, 103:1486 Hemicolectomy, right, ileocolonic transit after, 103:794 Hemodynamic alterations, in cirrhosis (rat), 103:275 Hemoglobin, gastric mucosal, in anemia (rat), 103:407 Hemorrhage, gastrointestinal in acute necrotizing pancreatitis (opossum), 103:205 endoscopic injection for-ss, 103:1358 norfloxacin prevents bacterial infection in cirrhotics with, 103:1267 trypsinogen-activation peptides and (rat), 103:1009 Hepatectomy, serum hepatocyte growth factor levels after, 103:1621 Hepatitis alcoholic IgA antibody to acetaldehyde adduct in alcoholic hepatitis, 103:1860 (rat), 1969-e nutritional therapy for, 103:357-c autoimmune, HLA class II molecules correlated with susceptibility to, 103:1041 chronic active, liver/kidney microsome type 1 antibodies in, 103:1290 neonatal, human cytomegalovirus correlated with, 103:1022 posttransfusion, assays of, 103:609 Hepatitis B virus (HBV) cirrhosis related to, octreotide in, 103:229,103:1992-c core antigen status, response to hepatitis B vaccine and, 103:590 DNA, in chronic hepatitis B after sustained loss of surface antigen, 103:1649

December

SUBJECT INDEX

1992

in end-stage liver disease, 103:1692-e in HBsAg-negative liver cancer, 103:1322

after liver transplantation, 103:1307, 103:1355-e polymerase chain reaction in detection of, 103:1098-e preS1 antigen, T-cell response to, 103:255 surface antigen in cirrhosis of the liver, 103:1630 sustained loss of, 103:1649 Hepatitis

C virus

(HCV)

acute posttransfusion, interferon 01in, 103:1702-ss antibody assays, of posttransfusion hepatitis, 103:609 antigen, immunomorphologic detection of (chimpanzee, humans), 103:622 cryoglubulinemia and, 103:1108-ss genomic variation of, 103:344-ss in HbsAg-negative liver cancer, 103:1322 interferon a for, 103:1285 interferon fl for, 103:1359-ss in liver transplantation, 103:317, 103:323, 103:338-e Hepatitis delta virus (HDV) antigen, prenylation of, 103:1978-ss Hepatocyte growth factor effects of, 103:1686-e serum levels of, in hepatectomized and nonhepatectomized surgical patients, 103:1621 Hepatocytes plg receptor expression by (rat), 103:296 streaming of, bromobenzene in acceleration of (rat), 103:1273 HEPES buffer, aspirin effect on ion permeation pathways in antrum and (Necturus), 103:1475 Herpes simplex virus (HSV), in etiology of esophageal cancer, 103:1336-srr N-Hexahydrosiladifenidol [3H]methylscopolamine displacement by, 103:870 Hexose, actively transported, in boosted mucosal immune responsiveness (rat), 103:1162 High-density lipoprotein (HDL)-3 retroendocytosis, in enterocytes, 103:469 High-performance liquid chromatography (HPLC), of aspirin intake, 103:862 Hirschowitz, Basil I., presentation of Julius Friedenwald Medal to, 103:1720 Hispanics, Helicobacter pylori infection in, 103:813 Histamine chloramines, gut permeability in response to (rabbit), 103:1537 in enterochromaffinlike cells (rat), 103:897 gastric, gastric secretagogues in regulation of in vivo release of, 103:1123-c

in GMP-40 and platelet-activating factor expression-ss, 103:1700 HIV. See Human immunodeficiency virus HLA class II molecules autoimmune hepatitis susceptibility correlated with, 103:1041 preS1 antigen and, 103:255 HLA-DR on enteroglial cells in Crohn’s disease, 103:439 in postpartum autoimmune gastritis, 103:934 HLA DRw8, primary biliary cirrhosis and, 103:1118-c Human immunodeficiency virus (HIV) gastrointestinal tract peptides in, 103:18 rectal mucosal pathology in, 103:919 Human pancreatitis-associated protein, pancreatic transplantation and, 103:248 Human papillomavirus (HPV) in etiology of esophageal cancer, 103:1336-srr malignant degeneration of esophageal squamous papilloma associated with, 103:1119-c polymerase chain reaction in detection of, 103:1098-e Humoral factor, in hepatocyte growth factor production, 103:1689-e Hurry, intestinal, malabsorption secondary to, 103:1995-c Hydrochloric acid, duodenum perfused with (rat), 103:481 Hydrogen peroxide, in inflammatory bowel disease, 103:186 Hydrolases, large bowel, 103:1452 Hydrophobicity, surface, in Helicobocter pylori infection, 103:1486 Hydroxyl radical, in inflammatory bowel disease, 103:186 3-Hydroxy+methylglutaryl-coenzyme A (HMG-CoA) hepatic cholesterol metabolism in estrogen-treated men and, 103:1657 lovastatin inhibition of, 103:982 3-Hydroxy-%methylglutaryl-coenzyme A (HMG-CoA) reductase bile acids in suppression of, 103:1641 inhibitor, for gallstones, 103:1068-cr Hyolaryngeal excursion, maximal, during oropharyngeal swallowing, 103:823 Hypercholesterolemia, paravastatin for, 103:1068-cr Hyperdynamic circulation, in cirrhosis (rat), 103:275, 103:1909 Hyperemia, superficial, in cirrhosis (rat), 103:1048 Hypergammaglobulinemia, in alcoholic liver cirrhosis, 103:1296 Hypergastrinemia colon cancer correlated with, 103:1361ss hyperplasia of oxyntic enterochromaffinlike cells and (rat], 103:1596

2033

in postpartum autoimmune gastritis, 103:934 Hyperglycemia, acute, effect of on esophageal motility and lower esophageal sphincter pressure, x03:775 Hyperlactacidemia, in fatal neonatal liver failure in context of mitochondrial cytopathy, 103:1332-cr Hyperplasia large bowel, 103:1452 neurotensin-induced increase of (rat), 103:86 of oxyntic enterochromaffinlike cells [rat), 103:1596 thyroid hormone-induced (rat), 103:1529 Hypersensitivity, food, basic mechanisms of pathophysiology, 103:1075-srr Hyperthyroidism, effect of on small intestine (rat), 103:1529 Hypochlorite, in inflammatory bowel disease, 103:186 Hypotension, angiotensin role in intestinal vascular response to (dog), 103:57 Hypothalamus, adenylate cyclase-stimulating peptides in, 103:539 Hypothyroidism, effect of on small intestine (rat), 103:1529 Hypoxia, early midzonal oxidative stress preceding apoptosis due to (rat), 103:994

lipoprotein (LDL), hepatic cholesterol metabolism in estrogen-treated men and, 103:1657 ‘251[Tyr3]octreotide, receptor autoradiography of somatostatin receptors in human lymphoid tissue, 103:1207 IB, monoclonal antibody, granulocyte recruitment in ischemia/reperfusion-induced intestinal dysfunction and (cat), 103:807 IEC-6 epithelial cell line, intestinal, acute-phase induction of manganese superoxide dismutase in, 103:905 '251-lowdensity

IgA antibodies, to liver acetaldehyde adduct (rat), 103:1860 (rat), 1969-e with interleukin 6, in positive secretory feedback loop, 103:1296 receptor, expression of by cultured aged hepatocytes (rat), 103:296 IgG, in postpartum autoimmune gastritis, 103:934 IgM antibody, in interferon a therapy for hepatitis C, 103:1285 Deal pouch-anal anastomosis, shortchain fatty acids in pouch contents after, 103:1144 Ileocolonic junction, in transit of solid content through entire gut, 103:794 Ileum adaptive growth of, 103:462 in giardiasis (gerbil), 103:506

2034

GASTROENTEROLOGY Vol. 103, No. 6

SUBJECT INDEX

longitudinal muscle, motor neurons to (guinea pig), 103:961 motility, bile salts in (guinea pig), 103:29 mucosa, neurotensin effect on (rat), 103:1254 ontogeny of procholecystokinin maturation in (rat), 103:424 Peyer patches, somatostatin receptors in, 103:1207 transforming growth factor (Yreceptor binding sites in, 103:1427 Imipenem, pancreatic concentration of, 103:1902 Immune complex colitis, IL-1ra in blocking proinflammatory activity of endogenous interleukin-1 in (rabbit), 103:65 Immune response actively transported hexose in (rat), 103:1162 in cholestasis, 103:617 Immunofluorescence, indirect, in localization of eosinophil granule major basic protein, 103:137 Immunoperoxidase staining, of rectal mucosa in HIV infection, 103:919 Immunoproliferative small intestinal disease, lymphoma and macroamylasemia associated with, 103:1071-cr Impedance, effect of on esophageal emptying (cat), 103:708ss ‘“In, in scintigraphy of colonic transit, 103:37, 103:80 Incontinence, fecal, dynamic anal manometry of, 103:103 Indian childhood cirrhosis, in an American child, 103:1709-c Indirect immunofluorescence assay of anti-LKMl antibodies in chronic active hepatitis, 103:1290 of fibronectin in fat-storing cells in liver (rat), 103:1313 of neutrophil autoantibodies in ulcerative colitis, 103:456 Indirect immunoperoxidase method, tenascin presence in colon assessed via, 103:400 Indocyanine green clearance, octreotide and, 163:229 Indomethacin, effect of on chemiluminescence of inflamed colonic mucosal scrapings (rat), 103:177 Infants. See Neonates Infarction, intestinal, creatinine kinase isoenzymes in diagnosis of, 103:1106-ss Infection in cirrhosis with gastrointestinal hemorrhage, norfloxacin in prevention of, 103:1267 hemodynamic changes due to cirrhosis aggravated during (rat), 103:282 Infectious agents, in etiology of esophageal cancer, 103:1336-srr Inflammation in colon cancer, 103:1260

complex cellular recognition events in, 103:1700-ss in Helicobacter pylori infection (chimpanzee), 103:848 IL-1ra-induced inhibition of (rabbit), 103:65 interleukin-8 and neutrophils in, 103:341-ss Inflammatory bowel disease AGA Clinical Teaching Project and, 103:1704-br 4-aminosalicylic acid for, 103:1706-c antineutrophil cytoplasmic autoantibodies in relatives of patients with, 103:1706-c L-carnitine for-c, 103:1710 colon cancer risk and mortality in, 103:1444 cytokine messenger RNA profiles in, 103:1587 dysplasia development in, 103:1611 elemental vs. polymeric diet for, 103:1363-ss endotoxin in, 103:1437 epidemiology of, 103:696-e familial aggregation of, 103:514 fish oil for, 103:1096-e lysozyme gene expression in, 103:532 neoplastic progression in, 103:1602 pyostomatitis vegetans and primary sclerosing cholangitis as markers of, 103:668-cr reactive oxygen metabolites in, 103:186 survival and causes of death in, 103:954 trends in therapy for, 103:713-br vascular adhesion molecules in, 103:840 Inflammatory cell infiltration, in acute necrotizing pancreatitis (opossum), 103:205 Inflammatory diarrhea, mechanisms of, 103:710-ss Injection therapy, for bleeding ulcers, 103:1358 Injurin, in hepatocyte growth factor production, 103:1689-e 1,4,5-Inositol triphosphate, in lower esophageal sphincter circular muscle (cat), 103:1199 Interdigestive motility erythromycin in, 103:72 somatostatin 28 in, 103:974 Interferon a (IFN-a) in acute-phase induction of manganese superoxide dismutase in intestinal epithelial cell lines, 103:905 in hepatitis C, 103:1285, 103:1702-ss Interferon j3 (IFN-@), for hepatitis C virus infection, 103:1359-ss Interferon y (IFN--y) in chronic liver disease, 103:264 fibronectin synthesis in Ito cell regulated

by (rat), 103:1313

Interleukin 1 (IL-l), mRNA profile of in inflammatory bowel disease detected by PCR, 103:1587 Interleukin-1 receptor antagonist (IL-lra) human recombinant, in blocking proin-

flammatory activity of endogenous interleukin-1 in immune colitis (rabbit), 103:65 mRNA profile of in inflammatory bowel disease detected by PCR, 103:1587 Interleukin 18 (IL-l@), in chronic liver disease, 103:264 Interleukin 6 (IL-6) in acute-phase induction of manganese superoxide dismutase in intestinal epithelial cell lines, 103:905 in chronic liver disease, 103:264 in Crohn’s disease, 103:1120-c with IgA, in positive secretory feedback loop, 103:1296 mRNA profile of in inflammatory bowel disease detected by PCR, 103:1587 Interleukin 8 (IL-a) in acute inflammation, 103:341-ss mRNA profile of in inflammatory bowel disease detected by PCR, 103:1587 Interleukins, immune response in cholestasis and, 103:617 Internal medicine, br

textbook of, 103:1111-

Intestinal angulation, jejunal unstirred layer and (rat), 103:1460 Intestines in cystic fibrosis, 103:688-srr differential induction of MHC molecules on, 103:1777 (mouse) epithelial cell lines of, acute-phase induction of manganese superoxide dismutase in, 103:905 ethanol effects on mucosal protein content of(rat), 103:289 glutamine-dipeptide absorption in, 103:3 infarction of, creatinine kinase isoenzymes in diagnosis of, 103:1106-ss ischemic, reperfusion of (cat), 103:807 motility of, somatostatin 28 in, 103:974 vascular response of to hypotension (dog), 103:57 Intra-abdominal pressure, increased, effect of on esophageal peristalsis (cat), 103:708 Intraesophageal balloon bicarbonate secretion and, 103:1174 biomechanical wall properties and collagen content in partially obstructed esophagus and (opossum), 103:1547 in identification of abnormal esophageal clearance response to intraluminal distension, 163:943 primary esophageal peristalsis and, 103:876 Intrahepatic portacaval shunts, in control of variceal bleeding prior to liver transplantation, 103:1357-ss Intraluminal distension, in esophagitis, abnormal esophageal clearance response to, 103:943 Ion permeation pathways, antral, aspirin effect on (Necturus), 103:1475

December

1992

Ion transport

across colonic mucosa, prostaglandin D, in (rat), 103:781 intestinal, pituitary adenylate cyclaseactivating polypeptide-stimulated, 103:539 IRD-98 epithelial cell line, intestinal, acute-phase induction of manganese superoxide dismutase in, 103:905 Iron aminosalicylates in chelation of, 103:1991-c excretion, bile salt-induced [rat), 103:1707-c pigments, in fatal neonatal liver failure in context of mitochondrial cytopathy, 103:1332-cr Irritable bowel syndrome chronic diarrhea in, 103:168 REM sleep abnormalities in, 103:12 scintigraphic colonic transit test in, 103:37 Ischemia/reperfusion injury, in induction of mucosal dysfunction (cat], 103:807 Islet cell tumors, endoscopic ultrasonography of, 103:711-ss Isometric contractions, induced by bile salts (guinea pig], 10329 Isoproterenol internal anal sphincter resting pressure decreased by (opossum], 103:43 lower esophageal sphincter pressure decreased by, 103:377 Isovolemic hemidilution, anemia induced by (rat], 103:407 Ispaghula gel, in accelerated proximal colon transit, 103:1167 Italy, familial aggregation of inflammatory bowel disease in, 103:514 Ito cells, fibronectin synthesis in, 103:1313 Japan, HLA class II molecules and autoimmune hepatitis in, 103:1041 Jaundice in HBsAg-positive cirrhosis of the liver, 103:1630 intermittent, by tumor emboli from intrahepatic cholangiocarcinoma, 103:1669-cr neonatal, effect of diet on, 103:660 obstructive, antioxidant defenses in (rat), 103:1625 in septuagenarian, with bloody diarrhea and sepsis, 103:1349-cc Jejunoileal resection, adaptive bowel growth after, 103:462 Jejunum brush border enzyme gene, thyroid hormone in differential regulation of (rat], 103:1529 in giardiasis (gerbil), 103:506 gliadin immune reactivity in, 103:1517 migrating motor complexes in (dog], 103:759 mucin and protein release in, bethane-

SUBJECT INDEX

chol and vagal nerve stimulation effects on, 103:496 mucosa, neurotensin effect on (rat), 103:1254 ontogeny of procholecystokinin maturation in (rat), 103:424 transforming growth factor (Yreceptor binding sites in, 103:1427 transit and motility, after Roux gastrojejunostomy, 103:1133 unstirred layer (rat), 103:1460 Julius Friedenwald Medal, presentation of to Basil I. Hirschowitz, 103:1720 Juxtacrine system, for adhesion and activation of neutrophils, 103:1700-ss K+ gradient,

in hepatic thiamine transport (rat), 103:1056 Kearns-Sayre syndrome, cervical dysphagia in, 103:1328-cr a-Keto-isocaproic acid, in cirrhosis, 103:571 &Keto-prostaglandin F,, antibodies, in gastric ulcer formation [rabbit), 103:1467 in lipopolysaccharide-stimulated Kupffer cells (rat), 103:1026 Kidneys blood flow in, endotoxin and plateletactivating factor effects on (rat), 103282 insensitivity of, to atria1 natriuretic peptide in patients with cirrhosis and ascites, 103:1710-c insufficiency, in sterile pancreatic necrosis, 103:1636 response of to amino acid infusion in cirrhosis, 103:601 somatostatin effects on in cirrhosis, 103:1868 in sterile pancreatic necrosis, 103:1636 K-ras gene, in pancreatic cancer, 103:982 induction Kupffer cells, cycle-oxygenase in (rat), 103:1026 L-683,536 leukotriene synthesis inhibitor, aspirin-induced leukocyte adhesion prevented by (rat), 103:146 Lactase gene expression, during early development of small intestine (rat), 103:1154 intestinal brush border, thyroid hormone in differential regulation of (rat), 103:1529 protein, patchy expression of in intestine, 103:1739 (rat, rabbit) L-Lactate, in pouchitis outputs, 10~1144 Lactulose in accelerated proximal colon transit, 103:1167 in osmotic diarrhea, 103:545 Lamina propria in HIV infection, 103:919 lysozyme synthesis in, 103:532 tenascin in, 103:400

2035

Large bowel

cancer, focal lesions in abnormal epithelium, 103:1452 hyperplasia, focal lesions in abnormal epithelium, 103:1452 mucosal hydrolases in, 103:1452 Larynx, in pharyngeal clearance &ring swallowing, 103:128 Left-sided colitis, survival rates for, 103:954 Leucine

in cirrhosis, 103:571 ethanol effect on plasma levels of (rat), 103:289 Leukocytes

adhesion of, aspirin and salicylate in (rat), 103:146 migration, into sites of active inflammatory bowel disease involvement, vascular adhesion molecules in, 103:840 Leukotriene B4 (LTB,) IL-lra effect on levels of [rabbit), 103:65 in leukocyte adhesion and emigration (rat), 103:146 Leukotriene C, (LTC,), after chronic superficial injury to gastric mucosa (rat), 103:1179 Leu-M3+ cells, in postpartum autoimmune gastritis, 103:934 Lewis antigen expression, in upper gastrointestinal epithelium, 103:1552 Lieber-DeCarli feeding technique, metabolic effects of long-term ethanol consumption and (rat), 103:289 Light microscopy, in acute necrotizing pancreatitis (opossum), 103:205 Lipase inhibitor, in experimental pancreatitis (rat), 103:1916 pancreatic, somatostatin 28 effect on levels of, 103:240 serum assay, glycerol interference in, 103:1066-cr Lipase/amylase ratio as etiologic index, 103:353-c lack of specificity of, 103:352-c Lipid peroxidation, in obstructive jaundice (rat], 103:1625 Lipopolysaccharide (LPS) in acute-phase induction of manganese superoxide dismutase in intestinal epithelial cell lines, 103:905 Kupffer cells stimulated with (rat), 103:1026 Lipoprotein pathway, in enterocytes, 103:469 5-Lipoxygenase inhibitor, effect of on chemiluminescence of inflamed colonic mucosal scrapings (rat], 103:177 Liquid swallows, oropharyngeal, monitoring of, 103:823 Lithocholic acid, bread ingestion and, 103:1246 Lithostathine, in inhibition of calcium carbonate precipitation, 103:1277

2036

SUBJECT INDEX

Lithotripsy, extracorporeal shock-wave, and ursodiol vs. ursodiol alone for gallstones, 103:311 Littoral cells, bromobenzene effect on (rat), 103:1273 Liver abcesses, in chronic pancreatitis, 103:560 acetaldehyde adduct, antibodies to, 103:1860 (rat), 1969-e antioxidant defenses and (rat), 103:1625 cancer DNA synthesis increase in surrounding cirrhoses and, 103:595 HBsAg-negative, hepatitis C and B viruses in, 103:1322 intermittent jaundice by tumor emboli from, 103:1669-cr cholesterol cholylsarcosine effects on (rat), 103:1641 metabolism of in estrogen-treated men, 103:1657 cirrhosis with ascites, thromboxane A, receptor blockade increases water diuresis in, 103:1017 atria1 natriuretic factor in, 103:1996-c ethanol-induced gastric damage in (rat), 103:1048 gastric blood flow in, 103:1875 HBsAg-positive, survival in, 103:1630 hepatocyte growth factor level in, 103:1621 HLA DRw8 and, 103:1118-c IgA and interleukin 6 form positive secretory feedback loop in, 103:1296 Indian childhood, in an American child, 103:1709-c nitric oxide modulation of hyperdynamic circulation in, 103:1909 (rat) octreotide in, 103:1992-c prognosis for, 103:1360-ss prostacyclin synthesis in, 103:1369-c renal insensitivity to atria1 natriuretic peptide in, 103:1710-c somatostatin effects in, 103:1868 in cystic fibrosis, 103:688-srr cysts, minocycline chloride for, 103:675-cr disease cytokines in, 103264 endotoxin effects in (rat), 103:282 hepatitis B-related end-stage, 103:1692-e nutritional therapy for, 103:357-c octreotide in, 103:229 platelet-activating factor effects in (rat), 103:282 portal-systemic shunt influence on circadian rhythms in (rat), 103:222 prognosis for, 103:1360-ss pyostomatitis vegetans presenting with, 103:668-cr therapy in, 103:1365-br vascular capacity in (rat), 103:275

GASTROENTEROLOGY Vol. 103, No. 6

visual event-related I’300 potentials in, 103:302 failure, in neonates, 103:1332-cr fat-storing cells, fibronectin synthesis in, 103:1313 idiopathic cholestatic dysfunction of, soft tissue sarcoma associated with, 103:330-cr in infants with human cytomegalovirus and neonatal hepatitis, 103:1022 intracinar enzyme profile, effect of age and sex on, 103:351-c metastases, porphyrins in (rat), 103:647 methylbenzylnitrosamine metabolism in (rat), 103:800 nitric oxide in, 103:1928 pig receptor expression in (rat), 103:296 piroxicam effects on, 103:354-c regeneration hepatocyte growth factor in, 103:1688 selective bowel decontamination and, 103:1993-c sinusoids, IgA in, 103:1296 thiamine transport in (rat), 103:1056 toxicity, of mesalazine, 103:1925-cr transplantation fibrosing cytolytic liver failure secondary to recurrent hepatitis B after, 103:1307 hepatitis B virus infection after, 103:1355-e hepatitis C virus infection in, 103:317 triglycerides, ethanol effect on (rat), 103:289 Liver/kidney microsome type 1 (antiLKMl) antibodies, in chronic active hepatitis, 103:1290 L-p-monomethyl-arginine (L-NMMA), anemia effects on gastric mucosal blood flow and (rat), 103:407 L-W-nitro arginine (L-NNA) in blocking internal anal sphincter relaxation (opossum), 103:43 in esophageal peristalsis (opossum), 103:197 in portal hypertension (rat), 103~35 L-W-nitro arginine methyl ester (L-NAME) in esophageal peristalsis (opossum), 103:197 nitric oxide role in neutrophil-mediated nitrosamine formation and (rat), 103:1260 Local intramural stimulation, in internal anal sphincter relaxation (opossum), 103:43 Locomotor activity rhythm, portal-systemic shunting and (rat), 103:222 Longitudinal muscle, ileal, motor neurons to (guinea pig), 103:961 Long-train electrical stimulation, primary peristalsis induced by (opossum), 103:197 Lovastatin, in inhibition of pancreatic cancer, 103:982 Low-calorie diet, in gallstone formation, 103:566

Low-density lipoprotein (LDL), hepatic cholesterol metabolism in estrogen-treated men and, 103:1657 Lower esophageal sphincter (LES) in achalasia, vasoactive intestinal polypeptide effect on, 103:377 biomechanical wall properties and collagen content in partially obstructed esophagus and (opossum), 103:1547 circular muscle, esophagitis impairs signal transduction in (cat), 103:1199 in nonspecific esophageal motor disorder with muscular hypertrophy, 103:333-cr pressure, acute hyperglycemia effect on, 103:775 quantitation of, 103:346-ss transient relaxation, pharyngeal catheter effect on, 103:1236 Loxiglumide in cephalic stimulation, 103:383 in gastric acid secretion, 103:1215 in gastrin secretion, 103:490 Lucigenin, in chemiluminescence amplification, colitis and, 103:186 Lumen, colonic short-chain fatty acids and, 103:336-e Luminal acid perfusion, of duodenum (rat), 103:481 Luminol, in chemiluminescence amplification, colitis and, 103:177 (rat), 103:186 Lymph node metastases, of colon cancer, 103:400 Lymphocytes, in rectal mucosa, in HIV infection, 103:919 Lymphocytic colitis, chronic diarrhea and, 103:168 Lymphocytosis, in mesalazine hypersensitivity reaction, 103:1925-cr Lymphoid tissue, gut, somatostatin receptors in, 103:1207 Lymphoma, immunoproliferative small intestinal disease associated with, 103:1071-cr Lysozyme, in inflammatory bowel disease, 103:532 Macroamylasemia, immunoproliferative small intestinal disease associated with, 103:1071-cr Macrophages Iysozyme synthesis in, 103:532 nitric oxide role in neutrophil-mediated nitrosamine formation and (rat), 103:1260 in postpartum autoimmune gastritis, 103:934 Magnesium hydroxide, osmotic diarrhea caused by, 103:545 Magnetic resonance imaging (MRI), of gastric emptying, 103:369 complex (MHC) Major histocompatibility molecules, differential induction of, 103:1777 (mouse)

December

SUBJECT INDEX

1992

Major histocompatibility complex (MHC) class II antigens, expression of on enteroglial cells in Crohn’s disease, 103:439 Malabsorption carbohydrate, in diarrhea, 103:545 in giardiasis (gerbil), 103:506 glucose/galactose, caused by defect in Na/glucose cotransporter, 103:1105-ss

secondary to intestinal hurry, 103:1995-c Malignant ascites, mobilization

of,

103:1302

Malonyldialdehyde, in obstructive jaundice (rat), 103:1625 Maltase, in neoplastic and hyperplastic large bowel lesions, 103:1452 Manganese superoxide dismutase (MnSOD), acute-phase induction of in intestinal epithelial cell lines, 103:905 Manometry in achalasia, 103:1993-c of cervical dysphagia in Kearns-Sayre syndrome, 103:1328-cr of esophageal motility, 103:775 of fecal incontinence, 103:103 of gastrointestinal motility, 103:114 of lower esophageal sphincter, 103:377 of nonspecific esophageal motor disorder with muscular hypertrophy, 103:333-cr of oropharyngeal swallowing, 103:823 of pharyngeal catheter effect on lower esophageal sphincter relaxation, 103:1236 of pharyngeal clearance during swallowing, 103:128 in prediction of feeding readiness in preterm infants, 103:1523 after Roux gastrojejunostomy, X03:1133 of upper esophageal sphincter belch reflex in achalasia, 103:1574 of Zenker’s diverticulum, 103:1229 Mast cells, intestinal, in gastrointestinal food hypersensitivity, 103:1075-srr MB&trier’s disease associated with formula protein allergy and small intestinal injury in an infant, 103:1664-cr transforming growth factor-a in (transgenie mice), 103:1950-rc Mesalamine. See 5-Aminosalicylic acid Mesalazine, severe hepatotoxicity to, 103:1925-cr Mesenteric venules, modulation of leukocyte adhesion in (rat), 103:146 Mesenteric vessels, nitric oxide-mediated hyporeactivity to vasopressors in (rat), 103235 Mesodermal tumors, paraneoplastic syndromes associated with, 103:33&cr Messenger RNA (mRNA) alkaline phosphatase, 103:1529 atria1 natriuretic factor, 103:1996 c-myc, 103:1823

CYPIA, 103:1509 cytokine, 103:1587 elongation factor 1 y, in colon cancer, 103:98 interleukin 6, 103:1296 lactase, 103:1154, 1529 lysozyme, 103:532 manganese superoxide dismutase, 103:905 ornithine decarboxylase, 103:462 parietal cell, 103:870 proglucagon, 103:462 Metaplasia blood group-related antigens and, 103:1552 lysozyme gene expression in, 103:532 Methacrylate, in scintigraphic colonic transit test, 103:37 Methionine-enkephalin, in cholestasis (rat), 103:630 Methylbenzylnitrosamine metabolism, zinc inhibition of (rat), 103:800 Methylcellulose, as vehicle for proton pump inhibitor (rat), 103:1596 3-O-Methyl-o-glucose. in giardiasis (gerbil), 103:506 &Methyl glucoside, in immune response (rat), 103:1162 N-Methylnicotinamide, in identification of sinusoidal organic cation/H+ antiport (rat), 103:1056 N-[3H]Methylscopolamine,displacement of by muscarinic agonists, 103:870 Metronidazole, pancreatic concentration of, 103:1902 Mevalonic acid, in reversal of lovastatininduced inhibition of pancreatic cancer cell growth, 103:982 Mezlocillin, pancreatic concentration of, 103:1902 MIA Paca2 cell line, lovastatin inhibition of growth of, 103:982 Microfluorography, of early midzonal oxidative stress preceding apoptosis in hypoxic liver (rat), 103:994 Microscopic colitis, subepithelial collagen table thickness in, 103:1790 Microsomal function, recovery of (rat), 103:579 Microspheroliths, in prediction of gallstone calcification, 103:552 Microvesicular steatosis, in fatal neonatal liver failure in context of mitochondrial cytopathy, 103:1332-cr Midzonal oxidative stress, early, preceding cell death in liver (rat), 103:994 Migrating motor complexes (MMCs) adrenergic blockade and (dog), 103:1491 duodenal, enterohepatic circulation in regular cycling of (dog), 103:759 erythromycin effect on, in diabetic gastroparesis, 103:72 somatostatin 28 effects on, 103:974 Migration, enterocyte, in giardiasis (gerbil), 103:506 Minocycline chloride, for liver cysts, 103:675-cr

2037

5-Minosalicylic acid, for Crohn’s disease, 103:363 Misoprostol, aspirin-induced leukocyte adhesion prevented by (rat), 103:146 Missense mutations, p53 gene, in gastric and esophageal cancers, 103:892 Mitochondrial cytopathy, in neonatal liver failure, 103:1332-cr Mitomycin C, colitis induced by (rat), 103:177 Mixed meal, scintigraphy of ileocolonic transit post-right hemicolectomy after, 103:794 MK-571 LTD, antagonist, effect of on aspirin-induced leukocyte adhesion (rat), 103:146 MK-866 5-lipoxygenase inhibitor, effect of on chemiluminescence of inflamed colonic mucosal scrapings (rat), 103:177 Mortality rates for chronic liver diseases, 103:1360-ss for colon cancer, 103:1444 for HBsAg-positive liver cirrhosis, 103:1630 for inflammatory bowel disease, 103:954 for peptic ulcer disease, 103:1192 for primary sclerosing cholangitis, 103:1893 for sterile pancreatic necrosis, 103:1636 Mosaicism, Caco-2 cell, 103:414 Motilin erythromycin effect on plasma levels of, in diabetic gastroparesis, 103:72 somatostatin 28 effects on, 103:974 Motility gastrointestinal bile salts in (guinea pig), 103:29 somatostatin 28 in, 103:974 Motor neurons, to ileal longitudinal muscle (guinea pig), 103:961 Motor responses, gastrointestinal, cephalic stimulation of, 103:383 Mucin in obstructive jaundice, 103:1669-cr release of in jejunum, bethanechol and vagal nerve stimulation effects on (rabbit), 103:496 synthesis, physiological regulation of, 103:1842 (dog) Mucobilia, from intrahepatic cholangiocarcinoma, intermittent jaundice by, 103:1669-cr Mucosal hydrolases, large bowel, 103:1452 Mucosal hydrophohicity, in Helicobacter pylori infection, 103:1486 Mucosal necrosis, colonic, IL-lra effect on levels of (rabbit), 103:65 Mucosal protection, long-term adaptive (rat), 103:1179 Mucous cells, physiological regulation of (dog), 103:1842 Muscarinic cholinergic blockade, in mutin release (rabbit), 103:496 Muscarinic receptors, m3 subtype, in parietal cells (rabbit), 103:870

2038 SUBJECT INDEX

Muscularis propria, thickened esophageal, nonspecific esophageal motor disorder associated with, 103:333-cr Myeloperoxidase effect of on chemiluminescence of inflamed colonic mucosal scrapings, 103:77 [rat), 103:186 granulocyte recruitment in ischemia/ reperfusion-induced intestinal dysfunction and (cat), 103:807 IL-lra effect on colonic levels of (rabbit), 103:65 Myenteric neurons denervation of, epithelial cell proliferation and, 103:1122-c to ileal longitudinal muscle (guinea pig), 103:961 Myoelectric activity, postoperative gastric, 103:1811 2ZNa absorption, colonic, endotoxin-induced alteration in (rat), 103:1437 Na’ in hepatic thiamine transport (rat), 103:1056 sorbin effect on duodenal absorption of (rat), 103:1568 transport, in basolateral membrane vesicles, 103:1817 Nafamostat mesilate (FUT), in experimental pancreatitis, 103:1916 (rat) Na+/H+ antiporter, in pH, regulation in esophageal epithelial cells (rabbit), 103:830 Na/glucose cotransporter, defect in, glucose/galactose malabsorption caused by, 103:1105-ss l-Naptho-2,3-triazole, nitric oxide role in neutrophil-mediated nitrosamine formation and (rat), 103:1260 Nausea, in food allergy, 103:1075-srr Necrosis, sterile pancreatic, 103:1636 Necturus antrum, effects of aspirin on pathways of ion permeation in, 103:1475 Neocholangioles, proliferative, in fatal neonatal liver failure in context of mitochondrial cytopathy, 103:1332cr Neonates diet effect on feces and jaundice in, 103:660 human cytomegalovirus correlated with hepatitis in, 103:1022 liver failure and mitochondrial cytopathy in, 103:1332-cr manometry in prediction of feeding readiness in, 103:1523 Menetrier’s disease in, 103:1664-cr Neoplastic progression, in chronic ulcerative colitis, 103:1602 Netiimicin, pancreatic concentration of, 103:1902 Neuronal phosphoproteins, in HIV infection, 103:18 Neurons enteric, bile salt inhibition of (guinea pig), 103:29

GASTROENTEROLOGYVol.103,No.6

to ileal longitudinal muscle (guinea pig), 103:961 secretomotor, action site of prostaglandin D, antisecretory mechanism localized in (rat), 103:781 in sensory innervation of esophagus (cat), 103:817 Neuropeptide Y (NPY), in HIV infection, 103:18 Neurotensin in colonic mucosal growth (rat), 103:86 in HIV infection, 103:18 in gut mucosal growth (rat), 103:1254 prostaglandin D, in inhibition of, 103:781 Neurotransmitters, in lower esophageal sphincter relaxation, 103:377 Neutrophil autoantibodies, in ulcerative colitis, 103:456 Neutrophil-derived oxidants, in inflammatory bowel disease, 103:186 Neutrophils in acute inflammation, 103:341-ss ELAM-1 in, 103:840 juxtacrine system for adhesion and activation of, 103:1700-ss in nitrosamine formation (rat), 103:1260 NH&I prepulse, in determination of pHi regulation in esophageal epithelial cells (rabbit), 103:830 Nicotinic ganglionic stimulant, in internal anal sphincter relaxation (opossum), 103:43 Nitric oxide anemia effects on gastric mucosal blood flow and (rat), 103:407 in esophageal peristalsis (opossum), 103:197 in gastrointestinal and hepatic function and disease, 103:1928 as gut smooth muscle-inhibitory mediator (opossum), 103:43 in neutrophil-mediated nitrosamine formation (rat), 103:1260 in portal hypertension (rat), 103:235 splanchic hemodynamics in cirrhosis and, 103:1909 (rat) Nitrogen balance, ethanol effects on (rat), 103:289 urinary excretion of, as marker for protein breakdown in cirrhosis, 103:571 4-Nitrophenol, in colon cancer, 103:448 Nitrosamine, nitric oxide in neutrophilmediated formation of (rat), 103:1260 Nodose ganglion, vagal sensory neurons in (cat), 103:817 Non-A, non-B (NANB) hepatitis, after liver transplantation, 103:323 Nonadrenergic, noncholinergic (NANC) nerve stimulation, internal anal sphincter relaxation in response to (opossum), 103:43 Noncardiac chest pain, esophagus in, 103:1698-ss

Nonstarch polysaccharides, in colon cancer, 103:1783,1964-e Nonsteroidal anti-inflammatory drugs (NSAIDs), in gastrointestinal bleeding, 103:862 Norfloxacin, prevents infections in cirrhotis, 103:1267 N-terminal sequences, proteolytic processing of, ontogeny of procholecystokinin maturation in intestine and (rat), 103:424 Nutritional deficiencies, in etiology of esophageal cancer, 103:1336-srr obesity, in gallstone formation, 1033566 Obstructive respiratory disease, inflammatory bowel disease survival and mortality rates correlated with, 103:954 Octreotide in hepatitis B-related cirrhosis, 103:1992-c in portal hypertension, 103:229 Ofloxacin, pancreatic concentration of, 103:1902 Omega-3 fatty acids colon cancer and, 103:1096-e in rectal mucosal cell proliferation in subjects at risk for colon cancer, 103:883 Omeprazole 24-hour intragastric acidity in duodenal ulcer and, 103:913 CYPlA gene induction by, 103:1509 in gastric ulcers (rabbit), 103:1467 in hyperplasia of histamine-depleted enterochromaffinlike cells in stomach (rat), 103:897 for Zollinger-Ellison syndrome, 103:1498 ONO-3708 thromboxane receptor A, antagonist, in cirrhosis with ascites, 103:1017 Opioids, in cholestasis (rat), 103:630 Oral lesions, in pyostomatitis vegetans, 103:668-cr Ornithine decarboxylase in adaptive bowel growth after jejunoileal resection, 103:462 adenomatous polyp status and, 103:1562 in colon cancer, estradiol effect on expression of (mouse), 103:1823 pituitary adenylate cyclase activating peptide modulation of (rat), 103:1002 Oropharyngeal swallowing, in normal adults, 103:823 Osmotic gap diarrhea and, 103:702-e of fecal fluid, 103:545 Ovalbumin, in immune response (rat), 103:1162 Oxidative metabolism, human phagocyte, Helicobacter pylori in, 103:1747 Oxidative phosphorylation deficiency, in mitochondrial cytopathies, 103:1332-cr

December

1992

Oxygen content, of gastric mucosa, in anemia (rat), 103:407 Oxygen free radicals in hypoxic liver (rat), 103:994 superoxide dismutases in reduction of, 103:905 Oxyntic mucosa gastrin as trophic factor for (rat), 103:1596 in postpartum autoimmune gastritis, 103:934 Oxypurinol, effect of on chemiluminescence of inflamed colonic mucosal scrapings, 103:186 p21 ras protein, in pancreatic cancer, 103:982 p24 protein, in rectal mucosa, in HIV infection, 103:919 p53 gene mutations, in gastric and esophageal cancers, 103:892 ~53 LOH, loss of heterozygosity for, in neoplastic progression in ulcerative colitis, 103:1602 ~53 protein, in Barrett’s esophagus, 103:1121-c P-170 glycoprotein, in colon cancer, 103:448 P300 event-related potentials, in early portosystemic encephalopathy, 103:302 Pacemaker role, played by fibronectins in liver fibrogenesis, 103:1313 Pacing, of stomach, 103:1811, 1967-e Palatine tonsils, somatostatin receptors in, 103:1207 PANCl cell line, lovastatin inhibition of growth of, 103:982 Pancolitis, survival rates for, 103:954 Pancreas bactericidal antibiotic concentration in, 103:1902 bicarbonate secretion in, 103:1674+rr cancer elongation factor 1 y-related RNA in, 103:98 iovastatin in inhibition of, 103:982 transforming growth factor (Yin, 103:1851 in cystic fibrosis, 103:687-srr endocrine tumors of, 103:1982-ss enzymes, in severe esophagitis, 103:855 exocrine, somatostatin 28 in inhibition of, 103:240 injury, false indication of on serum Iipase assay, 103:1066-cr juices, lithostathine in, 103:1277 secretion adrenergic tone and, 103:990 somatostatin 28 in, 103:974 sterile necrosis of, 103:1636 in TGF-(Y transgenic mice, 103:1883 transplantation, exocrine protein associated with, 103:248 tumor cell line, pituitary adenylate cyclase activating peptide effects on growth of (rat), 103:1002

SUBJECT INDEX

Pancreatic polypeptide in cephalic stimulation, 103:383 as measure of vagal-cholinergic tone, 103:775 Pancreatitis acute, biliary sludge in, 103:1104-ss acute necrotizing, acinar cells in (opossum), 103:205 chronic blood flow in (cat), 103:652 pancreatic and hepatic abcesses in, 103:560 experimental, treatment of, 103:1916 (rat) experimental acute, trypsinogen-activation peptides in (rat), 103:1009 hpase/amyiase ratio in, 103:352, 353-c Paneth cell metaplasia, lysozyme synthesis in, 103:532 Papilloma, esophageal squamous, malignant degeneration of, 103:1119-c Paraneoplastic hepatopathy, soft tissue sarcoma associated with, 103:330-cr Parasitology, medical, basic laboratory methods in, 103:714-br Parietal cells, m3 muscarinic receptor subtype in (rabbit), 103:870 PD 136450, effect of on endocrine cells during achlorhydria (rat), 103:1596 Pepsinogen, low levels of, in postpartum autoimmune gastritis, 103:934 Peptic ulcer disease aspirin in, 103:862 injection therapy for, 103:1358-ss periodicity of, 103:1192 surface hydrophobicity of gastric mucosa in, 103:1486 undergraduate teaching project on, 103:348-br Peptides, regulatory in adaptive bowel growth after jejunoiIeaI resection, 103:462 in cephalic stimulation, 103:383 in HIV infection, 103:lE preS1 antigen and, 103:255 Peptone, gastric acid secretion stimulated by, intestinal fat inhibition of (dog), 103:1221 Pericrypt eosinophilic enterocolitis, chronic diarrhea and, 103:168 Peripheral blood eosinohilia, in pyostomatitis vegetans, 103:668-cr lymphomononuclear cell stimulation, T-cell epitopes identified via, 103:255 mononuclear cells, IgA and IgG secretion by, 103:1296 reactive oxygen metabolites in inflammatory bowel disease and, 103:186 Peristalsis, esophageal nitric oxide role in (opossum), 103:197 wave of inhibition precedes, 103:876 Peritoneal carcinomatosis, ascites caused by, 103:1302 Peritonitis, in cirrhosis with gastrointes-

2039

tinal hemorrhage, norfloxacin in prevention of, 103:1267 Permeability, gut, in response to histamine chloramines and chemotactic peptide (rabbit), 103:1537 Pertussis toxin, effects of on pituitary adenylate cyclase activating peptide-induced AR4-2J cell growth (rat), 103:1002 Peyer patches, ileal, somatostatin receptors in, 103:1207 PH aspirin effect on ion permeation pathways in antrum and (Necturus), 103:1475 in esophageal bicarbonate secretion, 103:1174 in esophageal epithelial cells (rabbit), 103:830 in esophagitis, 103:855 in experimental diarrhea, 103545 in gastric ulcer formation (rabbit), 103:1467 in hepatic thiamine transport (rat), 103:1056 Phagocytes Helicobacter pylori and, 103:1747 reactive oxygen metabolites in inflammatory bowel disease and, 103:186 Pharyngeal clearance, during swallowing, 103:128 Pharyngeal diverticulum, pathophysiology of, 103:1229 Pharyngeal pressures, during oropharyngeal swallowing, 103:823 Pharyngeal stroking, primary peristalsis induced by (opossum), 103:197 Pharyngoesophageal function, deglutitive, in Kearns-Sayre syndrome, 103:1328-cr Pharynx catheter, in transient lower esophageal sphincter relaxation, 103:1236 Phenobarbital, in induction of cirrhosis (rat), 103:275 Phenolphthalein, secretory diarrhea caused by, 103:545 Phentolamine in adrenereic modulation of interdigestive pincreatic secretion, 103:990 migrating motor complex not affected by (dog), lo3:14m in mucin release (rabbit), 103:496 Phlorizin, in immune response (rat), 103:1162 Phosphadiesterase inhibitor, in duodenal mucosal bicarbonate secretion, 103:153 Phospholipids, secretion of, physiological regulation of (dog), 103:1842 *Photodynamic therapy, for liver tumors (rat), 103647 Photofrin II, in selective porphyrin accumulation in tumors (rat), 103:647 Piperacillin, pancreatic concentration of, 103:1902 N-Pirenzepine, [3H]methylscopolamine displacement by, 103:870

2040

GASTROENTEROLOGY Vol. 103, No. 6

SUBJECT INDEX

Piroxicam, hepatotoxicity of, 103:354-c Pituitary adenylate cyclase-activating polypeptide effects of on AR4-2J cell growth and ornithine decarboxylase activity (rat), 103:1002 stimulates secretion in T, cells, 103:539 Pituitary gland, adenylate cyclase secretion in, 103:539 Plasma glucagonlike peptide I (GLP-I), in adaptive bowel growth after jejunoileal resection, 103:462 Plateau-advancing contact angle, in assessment of surface hydrophobicity of gastric mucosa, 103:1486 Platelet-activating factor (PAF) expression of by endothelium stimulated by histamine or thrombin, 103:1700-ss hemodynamic effects of in cirrhosis (rat), 103:282 in leukocyte adhesion and emigration (rat), 103:146 Platelet cycle-oxygenase inhibition, to assay aspirin intake, 103:862 Platelets, in cirrhosis, storage pool defect in, 103:641 Pneumatic dilation, in achalasia, 103:1732 Point mutations, p53 gene, in gastric and esophageal cancers, 103:892 Polyethylene glycol (PEG), osmotic diarrhea caused by, 103:545 Polymerase chain reaction (PCR) in amplification of hepatitic C virus RNA, 103:317 CYPlA gene induction by omeprazole and, 103:1509 of cytokine mRNA profiles in inflammatory bowel disease mucosa, 103:1587 of hepatitis B virus DNA, 103:1649 of hepatitis C and B viruses in HbsAg-negative liver cancer, 103:1322 for hepatitis virus detection, 103:1098-e of human cytomegalovirus in livers of infants with neonatal hepatitis, 103:1022 of p53 gene mutations in gastric and esophageal cancers, 103:892 of parietal cell mRNA, 103:870 of posttransfusion hepatitis, 103:609 Polymerase chain reaction-restriction fragment length polymorphisms (PCR-RFLP) method, association between autoimmune hepatitis and HLA alleles assessed via, 103:1041 Polymeric diet, for Crohn’s disease, 103:1363-ss Polymeric immunoglohulin (pig) receptor, expression of by cultured aged hepatocytes (rat), 103:296 Polyps, colorectal fish oil effect on, 103:883 mucosal hydrqlases in, 103:1452 ornithine decarboxylase and, 103:1562

smoking and, 103:1370-c in ulcerative colitis, 103:433 Polysomnography, in irritable bowel syndrome, 103:12 Porphyrins, accumulation of in liver metastases (rat), 103:647 Portacaval anastomosis, circadian rhythms and (rat), 103:222 Portacaval shunts, intrahepatic, in control of variceal bleeding prior to liver transplantation, 103:1357-ss Portal hypertension ascites and, 103:1302 biliary cirrhosis with (rat), 103:579 cirrhosis with, increased gastric mucosal perfusion in, 103:1875 determinants of, 103:1990-c nitric oxide in (rat), 103:235 octreotide in, 103:229 somatostatin in, 103:1973-e Portal-systemic shunting, in circadian locomotor activity disruption (rat), 103:222 Portal vein ligation, circadian rhythms and (rat), 103:222 Postpartum period, autoimmune gastritis in, 103:934 Potassium chloride esophageal response to (cat), 103:1199 in isometric contraction of terminal ileum (guinea pig), 103:29 in portal hypertension (rat), 103:235 Pouchitis, after ileal pouch-anal anastomosis, 103:1144 Pravastatin, for gallstones, 103:1068-cr Prednisone, for pericrypt eosinophilic enterocolitis, 103:168 Pre-epithelial diffusion barrier, in jejunal perfusion (rat), 103:1460 Pregnancy, in development of autoimmune gastritis, 103:934 Prenylation, of large hepatitis delta virus antigen, 103:1978-ss preS1 antigen, T-cell response to, 103:255 Primary biliary cirrhosis HLA DRw8 and, 103:1118-c prognosis for, 103:1360-ss Primary esophageal peristalsis, wave of inhibition precedes, 103:876 Primary sclerosing cholangitis colon cancer and, in ulcerative colitis, 103:1707-c as inflammatory bowel disease marker, 103:668-cr survival models for, 103:1893 ursodiol for, 103:343-ss Procholecystokinin (proCCK), intestinal processing of during development (rat), 103:424 Proctitis, survival rates for, 103:954 Proglucagon, in adaptive bowel growth after jejunoileal resection, 103:462 Proliferating cell nuclear antigen (PCNA) in Barrett’s esophagus, 103:1769 in colonic epithelium (rat), 103:160 Proliferon, bromobenzene and (rat), 103:1273

Propidium iodide, in assay of early midzonal oxidative stress preceding apoptosis in hypoxic liver (rat), 103:994 Propionate, fecal content of after ileal pouch-anal anastomosis, 103:1144 Propranolol in adrenergic modulation of interdigestive pancreatic secretion, 103:990 migrating motor complex not affected by (dog), 103:1491 in mucin release (rabbit), 103:496 Prostacyclin, in cirrhosis, 103:1369-c Prostaglandin D, (PGD,) colonic secretion inhibited by (rat), 103:781 in lipopolysaccharide-stimulated Kupffer cells (rat), 103:1026 Prostaglandin E, (PGE,) after chronic superficial injury to gastric mucosa (rat), 103:1179 in duodenal mucosal bicarbonate secretion, 103:153 endotoxin-induced alteration in transport of (rat), 103:1437 in gallstone formation, 103:566 IL-1ra effect on colonic levels of (rabbit), 103:65 in lipopolysaccharide-stimulated Kupffer cells (rat), 103:1026 Prostaglandin I, (PGI,), aspirin-induced leukocyte adhesion prevented by (rat), 103:146 Prostate cancer, metastatic, estrogen therapy for, 103:1657 Protease inhibitor, in experimental pancreatitis (rat), 103:1916 Protein breakdown, in cirrhosis, 103:571 in colonic mucosa, neurotensin-induced increase of (rat), 103:86 enteric, in sarcoidosis, 103:355-c metabolism, ethanol effect on (rat), 103:289 release of in jejunum, bethanechol and vagal nerve stimulation effects on (rabbit), 103:496 Protein kinase, CAMP-dependent, endotoxin effect on colonic transport function and (rat), 103:1437 Proton pump inhibitor in gastric ulcers (rabbit), 103:1467 gastrin receptor antagonist effect on changes induced by (rat), 103:1596 pancreatic bicarbonate secretion and, 103:1674-srr Pseudopyloric metaplasia, lysozyme gene expression in, 103:532 Psychometric testing, visual event-related P300 potentials in, 103:302 Puberty, lithogenic bile after, 103:636 Pull-through static anal manometry, of fecal incontinence, 103:103 Pustules, friable, in pyostomatitis vegetans, 103:668-cr Pyloric motor response, adaptive changes

December

SUBJECT INDEX

1992

in, in response to intraduodenal dextrose, 103:1754 Pylorus adrenergic blockade and (dog), 103:1491 motility, intravenous erythromycin overcomes small intestinal feedback on, 103:114 Pyostomatitis vegetans, as inflammatory bowel disease marker, 103:668-cr Radioimmunoassay (RIA), of anti-HBc status, 103:590 Radiopaque marker method, for testing colonic transit, 103:37 Ranitidine effects of on blood alcohol levels after ethanol injection, 103:1102-ss surface hydrophobicity of gastric mucosa in Helicobacter pylori infection and, 103:1486 Ranson’s scores, in sterile pancreatic necrosis, 103:1636 Rapid Communications Possible role of transforming growth factor (Yin the pathogenesis of MBngtrier’s disease: supportive evidence from humans and transgenic Mice, 103:1950 Rapid eye movement (REM) sleep, abnormal, in irritable bowel syndrome, 103:lZ Rash, in mesalazine hypersensitivity reaction, 103:1925-cr RAS protein, in pancreatic cancer, 103:982 Reactive oxygen metabolites in colitis (rat), 103:177 in inflammatory bowel disease, 103:186 in inflammatory diarrhea, 103:710-ss Receptor autoradiography, of somatostatin receptors in human lymphoid tissue, 103:1207 Recombinant bacteria, oral innoculation of, against cholera toxin B (mouse), 103:520 Rectal balloon distension, rectoanal inhibitory reflex mimicked by (opossum), 103:43 Rectoanal inhibitory reflex, in relaxation of internal anal sphincter (opossum), 103:43 Rectum low-grade dysplasia of, 103:431 mucosa in HIV infection, 103:919 fish oil effect on, 103:883 ornithine decarboxylase in, adenomatous polyp status and, 103:1562 peptides, in HIV infection, 103:18 sporadic adenoma of, calcium in decrease of epithelial cell proliferation in, 103:92 Reflectance spectrophotometry, oxygen and hemoglobin content in gastric mucosa assessed via (rat), 103:407 Renzapride, gastroparesis validation with, 103:705-ss

Respiratory

chain activity,

in fatal neo-

natal liver failure in context of mitochondrial cytopathy, 103:1332-cr Respiratory disease, inflammatory bowel disease survival and mortality rates correlated with, 103:954 Retroendocytosis, high-density lipoprotein 3, in enterocytes, 103:469 Riboprobe in situ hybridization (rISH), demonstrates active lysozyme synthesis in inflammatory bowel disease, 103:532 Right and left colonic transit, after eating, 103:80 RNA colonic mucosal, neurotensin-induced increase of (rat), 103:86 hepatitis C virus, 103:317 Rough endoplasmic reticulum, in acute necrotizing pancreatitis (opossum), 103:205 Roux-en-Y choledochojejunostomy, after bile duct obstruction (rat), 103:579 Roux gastrojejunostomy, gastric and jejunal transit and motility after, 103:1133 S607 monoclonal antibody, intestinal fat effect on gastric function and (dog), 103:1221 Saccharides, pouch excretions of, 103:1144 Sacral nerve stimulation, in internal anal sphincter relaxation (opossum), 103:43 Salicylate, in leukocyte adhesion (rat), 103:146 Saliva esophageal acid infusion and, 103:1833 swallowed, perfusate bicarbonate contamination by, 103:1174 Saralasin, in intestinal vascular response to hypotension (dog), 103:57 Sarcoidosis, enteric protein losing in, 103:355-c SC-41930 LTB, antagonist, aspirin-induced leukocyte adhesion prevented by (rat), 103:146 Scatter factor, hepatocyte growth factor as, 103:1687-e Scintigraphy of biliodigestive anastomosis (rat), 103:579 of colonic transit, 103:37 of gastric emptying, 103:369 of ileocolonic transit after right hemicolectomy, 103:794 of lactulose-induced accelerated proximal colon transit, 103:1167 of right and left colonic transit, 103:80 after Roux gastrojejunostomy, 103:1133 Sclerosing cbolangitis, as inflammatory bowel disease marker, 103:668-cr Scopolamine, in mucin release (rabbit), 103:496 Scotland, Crohn’s disease in, 103:392 Seasonal variation, in peptic ulcer occurrence, 103:1192

2041

Second messenger, intracellular, in duodenal mucosal bicarbonate secretion, 103:153 Secondary biliary fibrosis, reversibility of by biliodigestive anastomosis (rat), 103:579

Secretagogues acid, mucin synthesis and phospholipid secretion regulated by, 103:1842 (dog)

gastric, in regulation of gastric histamine release in vivo, 103:1123-c Secretin, in exocytotic insertion of plasma pumps into basolateral plasma membrane, 103:1674-srr Secretory responses, gastrointestinal, cephalic stimulation of, 103:383 Selected Summaries Acalculous right upper quadrant pain: Is cholescintigraphy worthwhile? 103:1985 Acute hepatitis C infection: interferon finally succeeds, 103:1359 Bleeding esophageal varices-inject or band? 103:1979 Braving the elementals in Crohn’s disease, 103:1363 Can esophagus be blamed for noncardisc chest pain?, 103:1698 Complex cellular recognition events in acute inflammation, 103:1700 Does biliary sludge have the same significance as gallstones in acute pancreatitis? 103:1104 Eradication of Helicobacter pylori reduces gastric and duodenal ulcer occurrence, 103:1695 HZ-receptor antagonists and blood alcohol levels, 103:1102 Helicobacter pylori and non-ulcer dyspepsia, 103:340 Hepatitis C virus and cryoglobulinemia: unthawing the association, 103:1108 Hypergastrinemia and colonic neoplasia: coincidental or related?, 103:1361 Genomic variation of hepatitis C virus: clues to clinical variation?, 103:344 How does cholecystokinin contract the gallbladder? (guinea pig), 103:706 Injection therapy for bleeding ulcers: which solution is best?, 103:1358 Interferon-a in acute posttransfusion hepatitis C: a randomized, controlled trial, 103:1702 Interleukin 8, neutrophils, and acute inflammation, 103:341 Intrahepatic portocaval shunts: a new era?, 103:1357 Localization of islet cell tumors by endoscopic ultrasonography, 103:711 Lower esophageal sphincter: how to quantitate?, 103:346 Malabsorption: molecular biology to the bedside, 103:1105 Mechanisms of inflammatory diarrhea, 103:710

2042

SUBJECTINDEX

New treatment for primary sclerosing cholangitis: promising results with ursodiol, 103:343 Pancreatic endocrine tumors-seek and ye shall find, 103:1982 Prenylation of the large hepatitis delta virus antigen: a target for antiviral therapy, 103:1978 Prognosis in chronic liver diseases: Cox models, quantitative liver function tests, or both? 103:1360 The special problem of colitis in the elderly: expanding the spectrum, 103:1984 Towards an earlier diagnosis of intestinal infarction? 103:1106 The tricky business of testing drugs for gastroparesis, 103:705 What is intensive therapy for gastroesophageal reflux? 103:1696 When all the pressure and squeeze backfires (cat), 103:708 Selective bowel decontamination, liver regeneration and, 103:1993-c Selenium, in obstructive jaundice (rat), 103:1625 Semisolid swallows, oropharyngeal, monitoring of, 103:823 Sensitization, to foods, 103:1075-srr Sepsis, in septuagenarian, with bloody diarrhea and jaundice, 103:1349-cc Septicemia, after endoscopic retrograde cholangiopancreatography, 103:1367-c Serotonin, short-circuit current caused by (rat), 103:781 Serum lipase assay, glycerol interference in, 103:1066-cr Shaking, jejunal unstirred layer and (rat), 103:1460 Sham feeding, in cephalic stimulation, 103:383 Shock, in sterile pancreatic necrosis, 103:1636 Short chain fatty acids colonic, 103:336-e irrigation with, in ameliorating inflammation in diversion colitis, 103:51 in pouch contents after ileal pouch-anal anastomosis, 103:1144 Short-circuit current endotoxin and (rat), 103:1437 prostaglandin D, and (rat), 103:781 Short-train electrical stimulation, primary peristalsis induced by (opossum), 103:197 Sigmoid colon, low-grade dysplasia of, 103:431 Sigmoidoscopy, in routine management of ulcerative colitis, 103:431 Signal transduction, in lower esophageal sphincter circular muscle, esophagitis in impairment of (cat), 103:1199 Sinusoidal organic cation/H+ antiport, in hepatic thiamine transport (rat), 103:1056 Sinusoids, liver, IgA in, 103:1296

GASTROENTEROLOGYVol.103,No.6

Small bowel angiotensin role in intestinal vascular response to hypotension in, 103:57 brush border enzyme gene, thyroid hormone in differential regulation of (rat), 103:1529 eosinophil granule major basic protein deposition in, 103:137 immunoproliferative disease of, 103:1071-cr injury, neonatal Menetrier’s disease associated with, 103:1664-cr lactase gene expression during early development of (rat), 103:1154 malabsorption, in giardiasis (gerbil), 103:506 MHC class II antigen expression on in Crohn’s disease, 103:439 motility, bile salts in (guinea pig), 103:29 motor abnormalities, in waking state, 103:12 mucosa, neurotensin effect on (rat), 103:1254 Smooth muscle inhibitory-mediator, nitric oxide as (opossum), 103:43 SMS 201-995 somatostatin analog, in suppression of pituitary adenylate cyclase activating peptide-induced AR4-2J cell growth (rat), 103:1002 Socioeconomic status, presence of Helicobatter pylori infection correlated with, 103:813 Sodium in chronic superficial injury to gastric mucosa (rat), 103:1179 mucosal-to-serosal fluxes of in colon (rat), 103:781 sorbin effect on duodenal absorption of (rat), 103:1568 Sodium nitroprosside, in decrease of internal anal sphincter resting pressure (opossum), 103:43 Sodium sulfate, osmotic diarrhea caused by, 103:545 Soft tissue sarcoma, paraneoplastic hepatopathy associated with, 103:330-cr Solitary lymphatic follicles, colonic, somatostatin receptors in, 103:1207 Somatostatin as enterogastrone (dog), 103:1221 in HIV infection, 103:18 in portal hypertensive bleeding, 103:1973-e receptors, in germinal centers of human gut lymphoid tissue, 103:1207 renal effects of, in cirrhosis, 103:1868 Somatostatin 28 in exocrine pancreatic inhibition, 103:240 in interdigestive intestinal motility and pancreatic secretion, 103:974 Sorbin, in duodenal absorption of water and electrolytes (rat), 103:1568 Sorbitol, osmotic diarrhea caused by, 103:545 Special Reports and Reviews Gastrointestinal food hypersensitivity:

basic mechanisms of pathophysiology, 103:1075 Infectious agents in the etiology of esophageal cancer, 103:1336 The origin of and subcellular mechanisms causing pancreatic bicarbonate secretion, 103:1674 Role of nitric oxide in gastrointestinal and hepatic function and disease, 103:1928 Scientific advances in cystic fibrosis, 103:681 Spectrophotometry of fatal neonatal liver failure in context of mitochondrial cytopathy, 103:1332-cr oxygen and hemoglobin content in gastric mucosa assessed via (rat), 103:407 Spinal sensory neurons, in sensory innervation of esophagus (cat), 103:817 Splanchic vessels, nitric oxide-mediated hyporeactivity to vasopressors in (rat), 103:235 Spleen pulp pressure, portal hypertension and (rat), 103:579 Squamous cell carcinoma, esophageal, p53 gene mutation in, 103:892 Steatosis, in fatal neonatal liver failure in context of mitochondrial cytopathy, 103:1332-cr Sterile pancreatic necrosis, prognostic factors in, 103:1636 Stomach cancer in gastric remnant, 103:789 p53 gene mutations in, 103:892 comprehensive coverage of, 103:1365-br CYPlA gene induction in by omeprazole, 103:1509 eosinophil granule major basic protein deposition in, 103:137 fundus, transforming growth factor a! receptor binding sites in, 103:1427 hyperplasia of histamine-depleted enterochromaffinlike cells in (rat), 103:897 Lewis antigen expression in, 103:1552 motility, erythromycin effect on in diabetic gastroparesis, 103:72 mucosa, adaptive cytoprotection in, 103:1179 pacing of, 103:1811, 1967-e transit and motility, after Roux gastrojejunostomy, 103:1133 ulcer aspirin in, 103:862 gastric acid in prostaglandin-deficient conditions (rabbit) and, 103:1467 Helicobacter pylori eradication in reduction of, 103:1695-ss periodicity of, 103:1192 Stool, osmolality of, 103:702-e Storage pool defect, in cirrhotic platelets, 103:641

December

1992

Streaming, hepatocyte, bromobenzene in acceleration of (rat), 103:1273 Substance P in HIV infection, 103:18 in ileal cholinergic longitudinal muscle motor neurons (guinea pig), 103:961 short-circuit current caused by (rat), 103:781 Sucrase-isomaltase, in Caco-2 cells, 103:414 Sulfasalazine, hypersensitivity to, 103:1925-cr Superoxide, in inflammatory bowel disease, 103:186 Superoxide dismutase, effect of on chemiluminescence of inflamed coionic mucosal scrapings, 103:186 Surface hydrophobicity, in Helicobacter pylori infection, 103:1486 Surgical abdomen, due to Clostridium dificile-induced colitis, 103:355-c Surveillance, in routine management of ulcerative colitis, 103:431 Survival models, for primary sclerosing cholangitis, 103:1893 Survival rates, for inflammatory bowel disease, 103:954 Swallowing in Kearns-Sayre syndrome, 103:1328-cr oropharyngeal, in normal adults, 103:823 pharyngeal clearance during, 103:128 in Zenker’s diverticulum, 103:1229 Sydney system, in classification of chronic gastritis, 103:1113-c, 103:1116-c Systemic complications, in sterile pancreatic necrosis, 103:1636 T84 human colonic cells, reactive oxygen metabolites in, 103:710-ss Tachykinins, in ileal cholinergic longitudinal muscle motor neurons (guinea pig), 103:961 Taiwan hepatitis C and B viruses in HBsAg-negative liver cancer in, 103:1322 human cytomegalovirus correlated with neonatal hepatitis in, 103:1022 Taurine, effect of on chemiluminescence of inflamed colonic mucosal scrapings, 103:186 Taurocholate in anhepatic bile acid transport (rat), 103:1034 in isometric contraction of terminal ileum (guinea pig), 103:29 Taurodeoxycholate, in isometric contraction of terminal ileum (guinea pig), 103:29 Tauroursodeoxycholate, in isometric contraction of terminal ileum (guinea pig), 103:29 T-cells cholestasis-induced immune defect and, 103:617

SUBJECT INDEX

response of to hepatitis B virus preS1 antigen, 103:255 “““Tc-sulfur colloid, in scintigraphy of right and left colonic transit, 103:80 Tenascin, in colon disease, 103:400 Tetrahydrolipstatin (THL), in experimental pancreatitis, 103:1916 [rat) Tetrodotoxin in internal anal sphincter relaxation (opossum), 103:43 in isometric contraction of terminal ileum (guinea pig), 103:29 Theophylline, in duodenal mucosal bicarbonate secretion, 103:153 Thiamine, hepatic transpot of (rat), 103:1056 Thiry-Vella fistulas, neurotensin effect on gut mucosal growth and (rat), 103:1254 Thrombin, in GMP-40 and platelet-activating factor expression, 103:1700ss Thromboxane A, receptor blockade, increases water diuresis in cirrhosis with ascites, 103:1017 [3H]Thymidine autoradiography, of w-3 fatty acid effect on rectal mucosal proliferation, 103:883 Thymidine kinase, in giardiasis (gerbil), 103:506 Thymidine labeling calcium supplementation in suppression of, 103:92 proliferating cell nuclear antigen index correlated with (rat), 103:160 Thyroid hormone, in differential regulation of intestinal brush border enzyme gene expression (rat), 103:1529 Thyroiditis, postpartum, autoimmune gastritis correlated with, 103:934 Tissue section autoradiography, of transforming growth factor (Yreceptor binding sites in gut (dog), 103:1427 T-lymphocytes in postpartum autoimmune gastritis, 103:934 UCHLl-positive, MHC class II expression associated with, 103:439 Tobramycin, pancreatic concentration of, 103:1902 cr-Tocopherol analog, nitric oxide role in neutrophil-mediated nitrosamine formation and (rat), 103:1260 Training and Education in Gastroenterology American Gastroenterological Association Governing Board policy statement on, 103:1127 list of available training programs, 103:715 Transforming growth factor (Y(TGF-a) in Barrett’s esophagus, 103:1121-c in MB&trier’s disease, 103:1950-rc (transgenic mice) in pancreatic cancer cell differentiation,; 103:1851

2043

pancreatic overexpression of, 103:1883 (transgenic mice) receptor binding sites, in gut (dog), 103:1427 Transforming growth factor 8, (TGF-&), fibronectin synthesis in Ito cell regulated by (rat), 103:1313 Transfusion, hepatitis C virus infection after, 103:323 Transhepatic cholangiography needle, in minocycline chloride instillation in liver, 103:675-cr Transjugular intrahepatic portosystemic shunts, in control of variceal bleeding prior to liver transplantation, 103:1357-ss Transplantation liver fibrosing cytolytic liver failure secondary to recurrent hepatitis B after, 103:1307 hepatitis B virus infection after, 103:1355-e hepatitis C virus infection in, 103:317, 103:338-e, 103:323 pancreatic, exocrine protein associated with, 103:248 Trichinella spiralis somatic antigen, in immune response (rat), 103:1162 Triglycerides, liver, ethanol effect on (rat), 103:289 Triiodothyronine (T,), in differential regulation of intestinal brush border enzyme gene expression (rat), 103:1529 Trophic factor, gastrin as (rat), 103:1596 Trypsin adrenergic modulation of secretion of, 103:990 in calcium carbonate precipitation, 103:1277 somatostatin 28 effect on levels of, 103:240 Trypsinogen-activation peptides, in experimental pancreatitis (rat), 103:1009 Tryptophan, somatostatin 28 and, 103:240 Tuberculoid granulomas, lysozyme synthesis in, 103:532 Tumor emboli, from intrahepatic cholangiocarcinoma, intermittent jaundice by, 103:1669-cr Tumor necrosis factor (1 (TNF-a) in acute-phase induction of manganese superoxide dismutase in intestinal epithelial cell lines, 103:905 in chronic liver disease, 103:264 Tumor suppression, hepatocyte growth factor in, 103:1688 Tyrosine sulfation, ontogeny of procholecystokinin maturation in intestine and (rat), 103:424 U-46619 thromboxane receptor A, agonist, in cirrhosis with ascites, 103:1017

2044 SUBJECT INDEX

LJCHL-1 staining, of rectal mucosa in HIV infection, 103:919 UDP-glucuronyltransferase, expression of in colon cancer, 103:448 Ulcerative colitis 4-aminosalicylic acid for, 103:1706-c antineutrophil cytoplasmic autoantibodies in relatives of patients with, 103:1706-c butyrate enema effects on, 103:51 L-carnitine for, 103:1710-c colon cancer and primary sclerosing cholangitis in, 103:1707-c colon cancer risk and mortality in, 103:1444 cytokine messenger RNA profiles in, 103:1587 dysplasia development in, 103:1611 epidemiology of, 103:696-e familial aggregation of, 103:514 fish oil for, 103:1096-e low-grade dysplasia and cancer in, 103:431 lysozyme gene expression in, 103:532 neoplastic progression in, 103:1602 neutrophil autoantibodies in, 103:456 reactive oxygen metabolites in, 103:186 short-chain fatty acids in, 103:336-e survival and causes of death in, 103:954 vascular adhesion molecules in, 103:840 Ulcerative proctitis, survival rates for, 103:954 Ulcers aspirin in, 103:862 gastric acid in prostaglandin-deficient conditions and (rabbit), 103:1467 Helicobacter pylori eradication in reduction of, 103:1695-ss injection therapy for, 103:1358-ss omeprazole for, 103:913 periodicity of, 103:1192 surface hydrophobicity of gastric mucosa in, 103:1486 undergraduate teaching project on, 103:348-br Ultrasonography of islet cell tumors, 103:711-ss of minocycline chloride instillation in liver, 103:675-cr of nonspecific esophageal motor disorder with muscular hypertrophy, 103:333-cr of paravastatin-treated cholesterol gallstone, 103:1068-cr Upper esophageal sphincter (UES) belch reflex, in achalasia, 103:1574, 103:1685-e in Kearns-Sayre syndrome, 103:1328-cr

GASTROENTEROLOGY Vol. 103, No. 6

in oropharyngeal swallowing, 103:823 in pharyngeal clearance during swallowing, 103:128 in Zenker’s diverticulum, 103:1229 Uremia, effects of on gastric mucosal barrier (rat), 103:1762 Ursodeoxycholic acid, immunosuppressive effects of (mouse), 103:617 Ursodiol for gallstones, 103:311 for primary sclerosing cholangitis, 103:343-ss Vaccines for Helicobacter pylori gastritis (piglet), 103:1580 for hepatitis B virus infection, 103:255, 103:590 oral carrier, 103:699-e Vagal blockade, in abolishment of gastric migrating motor complex (dog), 103:1491 Vagal-cholinergic tone, pancreatic polypeptide as indirect measure of, 103:775 Vagal nerve stimulation in mucin and protein release in jejunum (rabbit), 103:496 primary peristalsis induced by (opossum), 103:197 Vagal sensory neurons, in sensory innervation of esophagus (cat), 103:817 Variceal bleeding control of prior to liver transplantation, 103:1357-ss in HBsAg-positive cirrhosis of the liver, 103:1630 treatment of, 103:1979-ss Vascular adhesion molecules, in inflammatory bowel disease, 103:840 Vascular capacity, in cirrhosis (rat), 103:275 Vascular cell adhesion molecule l(VCAM-l), in inflammatory bowel disease, 103:840 Vasoactive intestinal polypeptide (VIP) in achalasia, effect of on lower esophageal sphincter, 103:377 endotoxin-induced alteration in transport of (rat), 103:1437 in duodenal absorption of water and electrolytes (rat), 103:1568 in HIV infection, 103:18 pituitary adenylate cyclase-activating polypeptide and, 103:539, 103:1002 Vasoconstriction, hypotension-induced, angiotension II inhibitor effect on, 103:57

Vasopressors, mesenteric vessel, nitric oxide-mediated hyporeactivity to (rat), 103:235 Venous circulation, systemic, in cirrhosis (rat), 103:275 Vermiform appendix, somatostatin receptors in, 103:1207 Videofluoroscopy of oropharyngeal swallowing, 103:823 of pharyngeal clearance during swallowing, 103:128 Videoradiography, of Zenker’s diverticulum, 103:1229 Villus hyperplasia, thyroid hormone-induced (rat), 103:1529 Viremia, post-liver transplant, 103:317 Visual event-related potentials, in early portosystemic encephalopathy, 103:302 Vitamin B,,, low serum levels of, in postpartum autoimmune gastritis, 103:934 Vitamin E, in obstructive jaundice (rat), 103:1625 Vomiting, in food allergy, 103:1075-srr Waking state, small bowel motor abnormalities in, 103:12 Warfarin, in jejunal unstirred layer, 103:1460 Water colonic transport of, endotoxin-induced alterations in (rat), 103:1437 diuresis, thromboxane A, receptor-induced increase in, 103:1017 sorbin effect on duodenal absorption of (rat), 103:1568 Weight reduction, gallstone development during, 103:214 Whole grains, fecal bile acid pattern and, 103:1246 Xanthine oxidase, oxidative pendence on, 103:994

stress de-

Yersinia enterocolitica, as live oral carrier for cholera toxin B (mouse), 103:520 Yops, in oral immunization against cholera toxin B (mouse], 103:520 Zenker’s diverticulum, pathophysiology of, 103:1229 Zinc, inhibition of methylbenzylnitrosamine metabolism by (rat), 103:800 Zollinger-Ellison syndrome, omeprazole for, 103:1498